Advertisement

Introduction to Candida

Systemic Candidiasis
  • Judith E. Domer
  • Robert I. Lehrer
Part of the Infectious Agents and Pathogenesis book series (IAPA)

Abstract

Candidiasis is the prototypic opportunistic fungal disease. Candida spp. reside most commonly in the gastrointestinal tract1,2 and vagina, where they are normally held in check by as-yet incompletely defined local factors that include competition with the resident bacterial flora and innate effectors of nonspecific mucosal resistance.3,4 Infrequently, but under a wide variety of clinical circumstances, these normally inconspicuous commensals can multiply on or invade through the mucosal surface to initiate local or systemic disease. Various immunologic and nonimmunologic conditions can predispose to such opportunistic infections.5 Among the former are certain malignancies6–8 and the use of cytotoxic or immunosuppressive therapy.9,10 Nonimmunologic predisposing factors include diabetes,11 trauma,12 pregnancy,13 antibiotic therapy,7 and hyperalimentation.14 Not infrequently, such predisposing factors occur in combination.

Keywords

Candida Albicans Chronic Granulomatous Disease Invasive Candidiasis Bacille Calmette Guerin Systemic Candidiasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cohen, R., Roth, E J., Delgado, E., Ahearn, D. G., and Kaiser, M. H., 1969, Fungal flora of the normal human small and large intestine, N. Engl. J. Med. 280:638–641.PubMedCrossRefGoogle Scholar
  2. 2.
    Draser, B. S., and Hill, M. J., 1974, Human Intestinal Flora, Academic Press, New York.Google Scholar
  3. 3.
    Kennedy, M. J., 1989, Regulation of Candida albicans populations in the gastrointestinal tract: mechanisms and significance in GI and systemic candidiasis, Curr. Top. Med. Mycol. 3: 315–402.PubMedCrossRefGoogle Scholar
  4. 4.
    Budtz Jorgensen, E., 1990, Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infections, Acta Odontol. Scand. 48:61–69.PubMedCrossRefGoogle Scholar
  5. 5.
    Domer, J. E., and Carrow, E. W, 1989, Candidiasis, in: Immunology of the Fungal Diseases (R. A. Cox, ed.), CRC Press, Inc., Boca Raton, Florida, pp. 57–91.Google Scholar
  6. 6.
    Young, R. C., Bennett, J. E., Geelhoed, G. W, and Levine, A. S., 1974, Fungemia with compromised host resistance. A study of 70 cases, Ann. Intern. Med. 80:605–612.PubMedCrossRefGoogle Scholar
  7. 7.
    Parker, J. C., Jr., McCloskey, J. J., and Knauer, K. A., 1976, Pathobiologic features of human candidiasis. A common deep mycosis of the brain, heart and kidney in the altered host, Am. J. Clin. Pathol. 65:991–1000.PubMedGoogle Scholar
  8. 8.
    Horn, R., Wong, B., Kiehn, T. E., and Armstrong, D., 1985, Fungemia in a cancer hospital: changing frequency, earlier onset and results of therapy, Rev. Infect. Dis. 7:646–655.PubMedCrossRefGoogle Scholar
  9. 9.
    Pirsch, J. D., and Maki, D. G., 1986, Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow, Ann. Intern. Med. 104:619–631.PubMedCrossRefGoogle Scholar
  10. 10.
    Tollemar, J., Ringden, O., Bostrom, L., Nilsson, B., and Sundberg, B., 1989, Variables predicting deep fungal infections in bone marrow transplant recipients, Bone Marrow Transplantation 4:635–641.PubMedGoogle Scholar
  11. 11.
    Tapper-Jones, L., Aldred, M. J., Walker, D. M., and Hayes, T. M., 1981, Candidal infections and populations of Candida albicans in the mouths of diabetics, J Clin. Pathol. 34:706–711.PubMedCrossRefGoogle Scholar
  12. 12.
    Prasad, J. K., Feller, I., and Thomson, P. D., 1987, A ten-year review of Candida sepsis and mortality in burn patients, Surgery 101:213–216.PubMedGoogle Scholar
  13. 13.
    Ryley, J. E, 1986, Pathogenicity of Candida albicans with particular reference to the vagina, J. Med. Vet. Mycol. 24:5–22.PubMedCrossRefGoogle Scholar
  14. 14.
    Montgomerie, J. Z., and Edwards, J. E., Jr., 1978, Association of infection due to Candida albicans with intravenous hyperalimentation, J. Infect. Dis. 137:197–201.PubMedCrossRefGoogle Scholar
  15. 15.
    Karabinis, A., Hill, C., Leclercq, B., Tancrede, C., Baume, D., and Andremont, A., 1988, Risk factors for candidemia in cancer patients: a case-control study, J. Clin. Microbiol. 26: 429–432.PubMedGoogle Scholar
  16. 16.
    Bross, J., Talbot, G. H., Maislin, G., Hurwitz, S., and Strom, B. L., 1989, Risk factors for nosocomial candidemia: a case-control study in adults without leukemia, Am. J. Med. 87: 614–620.PubMedCrossRefGoogle Scholar
  17. 17.
    Odds, F. C., 1988, Candida and Candidosis, Bailliere Tindall, London, pp. 93–114.Google Scholar
  18. 18.
    Pfaller, M. A., 1988, Nosocomial Candida infections, Curr. Opin. Infect. Dis. 1:764–771.CrossRefGoogle Scholar
  19. 19.
    Rippon, J. W, 1988, Medical Mycology, The Pathogenic Fungi and the Pathogenic Actinomycetes, W. B. Saunders Company, Philadelphia, PA, pp. 532–581.Google Scholar
  20. 20.
    Spencer, P. M., and Jackson, G. G., 1989, Fungal and mycobacterial infections in patients infected with the human immunodeficiency virus, J. Antimicrob. Chemother. 23(suppl. A): 107–125.PubMedCrossRefGoogle Scholar
  21. 21.
    Klein, R. S., Harris, C. A., Small, C. B., Moll, B., Lesser, M., and Friedland, G. H., 1984, Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome, N. Engl. J. Med. 311:354–358.PubMedCrossRefGoogle Scholar
  22. 22.
    Tavitian, A., Raufman, J.-P., and Rosenthal, L. E., 1986, Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome, Ann. Intern. Med. 104: 54–55.PubMedCrossRefGoogle Scholar
  23. 23.
    Guentzel, M. N., Cole, G. T., and Pope, L. M., 1985, Animal models for candidiasis, Curr. Top. Med. Mycol. 1:57–116.PubMedCrossRefGoogle Scholar
  24. 24.
    Kreger-van Rij, N. J. W, 1984, The Yeasts. A Taxonomic Study, Elsevier Science Publishers B. V., Amsterdam, pp. 585–844.Google Scholar
  25. 25.
    Kiehn, T. E., Edwards, E. E, and Armstrong, D., 1980, The prevalence of yeasts in clinical specimens from cancer patients, Am. J. Clin. Path. 73:518–521.PubMedGoogle Scholar
  26. 26.
    Wingard, J. R., Merz, W. G., and Saral, R., 1979, Candida tropicalis: a major pathogen in immunocompromised patients, Ann. Intern. Med. 91:539–543.PubMedCrossRefGoogle Scholar
  27. 27.
    Meunier-Carpentier, E, Kiehn, T. E., and Armstrong, D., 1981, Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality, Am. j Med. 71:363–370.PubMedCrossRefGoogle Scholar
  28. 28.
    Walsh, T. J., and Merz, W. G., 1986, Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis, Am. J. Clin. Pathol. 85:498–502.PubMedGoogle Scholar
  29. 29.
    Howlett, J. A., 1976, The infection of rat tongue mucosa in vitro with five species of Candida, J. Med. Microbiol. 9:309–316.PubMedCrossRefGoogle Scholar
  30. 30.
    Allen, C. M., and Beck, E. M., 1987, Differences in mucosal reaction related to Candida albicans isolates, J. Oral Pathol. 16:89–93.PubMedCrossRefGoogle Scholar
  31. 31.
    Martin, M. V, Craig, G. T., and Lamb, D. J., 1984, An investigation of the role of true hypha production in the pathogenesis of experimental oral candidosis, Sabouraudia 22:471–476.PubMedCrossRefGoogle Scholar
  32. 32.
    Sobel, J. D., Muller, G., and Buckley, H. R., 1984, Critical role of germ tube formation in the pathogenesis of candidal vaginitis, Infect. Immun. 44:576–580.PubMedGoogle Scholar
  33. 33.
    Walsh, T. J., and Pizzo, P. A., 1988, Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation, Ann. Rev. Microbiol. 42:517–545.CrossRefGoogle Scholar
  34. 34.
    Hadfield, T. L., Smith, M. B., Winn, R. E., Rinaldi, M. G., and Guerra, C., 1987, Mycoses caused by Candida lusitaniae, Rev. Infect. Dis. 9:1006–1012.PubMedCrossRefGoogle Scholar
  35. 35.
    Dick, J. D., Rosenguard, B. R., Merz, W. G., Stuart, R. K., Hutchins, G. M., and Saral, R., 1985, Fatal disseminated candidiasis due to amphotericin B-resistant Candida guilliermondii, Ann. Intern. Med. 102:67–68.PubMedCrossRefGoogle Scholar
  36. 36.
    Pappagianis, D., Collins, M. S., Hector, R., and Remington, J., 1979, Development of resistance to amphotericin B in Candida lusitaniae infecting a human, Antimicrob. Agents Chemother. 16:123–126.PubMedCrossRefGoogle Scholar
  37. 37.
    Hasenclever, H.F., and Mitchell, W. O., 1961, Antigenic studies of Candida. I. Observations of two antigenic groups in Candida albicans,j. Bacteriol. 82:570–573.PubMedGoogle Scholar
  38. 38.
    Odds, E. C., and Abbott, A. B., 1980, A simple system for the presumptive identification of Candida albicans and differentiation of strains within the species, Sabouraudia 18:301–317.PubMedCrossRefGoogle Scholar
  39. 39.
    Odds, E. C., and Abbott, A. B., 1983, Modification and extension of tests for differentiation of Candida species and strains, Sabouraudia 21:79–81.PubMedCrossRefGoogle Scholar
  40. 40.
    McCreight, M. C., and Warnock, D. W, 1982, Enhanced differentiation of isolates of Candida albicans using a modified resistogram method, Mykosen 25:589–598.PubMedCrossRefGoogle Scholar
  41. 41.
    Polonelli, L., Archibusacci, C., Sestito, M., and Morace, G., 1983, Killer system: a simple method for differentiating Candida albicans strains, J. Clin. Microbiol. 17:774–780.PubMedGoogle Scholar
  42. 42.
    Roman, M. C., and Linaresicilia, M. J., 1983, Preliminary investigation of Candida albicans biovars, J. Clin. Microbiol. 18:430–431.PubMedGoogle Scholar
  43. 43.
    Lee, W, Burnie, J., and Matthews, R., 1986, Fingerprinting Candida albicans, j Immunol. Methods 93:177–182.PubMedCrossRefGoogle Scholar
  44. 44.
    Phongpaichit, S., Mackenzie, D. W. R., and Fraser, C., 1987, Strain differentiation of Candida albicans by morphotyping, Epidemiol. Infect. 99:421–428.PubMedCrossRefGoogle Scholar
  45. 45.
    Magee, B. B., D’Souza, T. M., and Magee, P. T., 1987, Strain and species identification by restriction fragment length polymorphisms in the ribosomal DNA repeat of Candida species, J. Bacteriol. 169:1639–1643.PubMedGoogle Scholar
  46. 46.
    Scherer, S., and Stevens, D. A., 1987, Application of DNA typing methods to epidemiology and taxonomy of Candida species, j Clin. Microbiol. 25:675–679.PubMedGoogle Scholar
  47. 47.
    Magee, B. B., and Magee, P. T., 1987, Electrophoretic karyotypes and chromosome numbers in Candida species, j Gen. Microbiol. 133:425–430.PubMedGoogle Scholar
  48. 48.
    Merz, W. G., Connelly, C., and Hieter, P., 1988, Variation of electrophoretic karyotypes among clinical isolates of Candida albicans,j Clin. Microbiol. 26:842–845.PubMedGoogle Scholar
  49. 49.
    Vaudry, W. L., Tierney, A. J., and Wenman, W. M., 1988, Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit, J. Infect. Dis. 158:1375–1379.PubMedCrossRefGoogle Scholar
  50. 50.
    Burnie, J. P., Odds, E. C., Lee, W, Webster, C., and Williams, J. D., 1985, Outbreak of systemic Candida albicans in intensive care unit caused by cross infection, Brit. Med. J. (Clin. Res.) 290:746–748.CrossRefGoogle Scholar
  51. 51.
    Odds, F. C., Palacio-Hernanz, A., Cuadra, J., and Sanchez, J., 1987, Disseminated Candida infection syndrome in heroin addicts—dominance of a single Candida albicans biotype, J. Med. Microbiol. 32:275–277.CrossRefGoogle Scholar
  52. 52.
    Neely, A. N., Odds, E C., Basatia, B. K., and Holder, I. A., 1988, Characterization of Candida isolates from pediatric burn patients, j Clin. Microbiol. 26:1645–1649.PubMedGoogle Scholar
  53. 53.
    Fox, B. C., Mobley, H. L. T., and Wade, J. C., 1989, The use of a DNA probe for epidemiological studies of candidiasis in immunocompromised hosts, J. Infect. Dis. 159: 488–494.PubMedCrossRefGoogle Scholar
  54. 54.
    Pfaller, M., 1989, Infection control: opportunistic fungal infections—the increasing importance of Candida species, Infect. Control Hosp. Epidemiol. 10:270–273.PubMedCrossRefGoogle Scholar
  55. 55.
    Stevens, D. A., Odds, E. C., and Scherer, S., 1990, Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype, Rev. Infect. Dis. 12: 258–266.PubMedCrossRefGoogle Scholar
  56. 56.
    Soll, D. R., Staebell, M., Langtimm, C., Pfaller, M., Hicks, J., and Gopala Rao, T. V., 1988, Multiple Candida strains in the course of a single systemic infection, J. Clin. Microbiol. 26: 1448–1459.PubMedGoogle Scholar
  57. 57.
    Burkholder, P. R., 1943, Vitamin deficiencies in yeasts, Am. j Botany 30:206–211.CrossRefGoogle Scholar
  58. 58.
    Drouhet, E., and Vieu, M., 1957, Facteurs vitaminiques de croissance des Candida, Ann. Inst. Pasteur 92:825–831.Google Scholar
  59. 59.
    Caroline, L., Taschdjian, C. L., Kozinn, P. J., and Schade, A. L., 1964, Reversal of serum fungistasis by addition of iron, j Invest. Dermatol. 42:415–419.PubMedGoogle Scholar
  60. 60.
    Masson, P. L., Heremans, J. F., and Schonne, E., 1969, Lactoferrin, an iron-binding protein in neutrophilic leukocytes, J. Exp. Med. 130:643–658.PubMedCrossRefGoogle Scholar
  61. 61.
    Bretz, U., and Baggiolini, M., 1974, Biochemical and morphological characterization of azurophil and specific granules of human neutrophilic polymorphonuclear leukocytes, J. Cell Biol. 63:251–269.PubMedCrossRefGoogle Scholar
  62. 62.
    Rado, T. A., Wei, X., and Benz, E. J., Jr., 1987, Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis, Blood 70:989–993.PubMedGoogle Scholar
  63. 63.
    Kirkpatrick, C. H., Green, I., Rich, R. R., and Schade, A. L., 1971, Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis, J. Infect. Dis. 124:539–544.PubMedCrossRefGoogle Scholar
  64. 64.
    McNamara, M. P., Wiessner, J. H., Collins-Lech, C., and Hahn, B. L., 1988, Neutrophil death as a defence mechanism against Candida albicans infections, Lancet 2:1163–1165.PubMedCrossRefGoogle Scholar
  65. 65.
    Sohnle, P. G., and Collins-Lech, C., 1990, Comparison of candidacidal and candidastatic activities of human neutrophils, Infect. Immun. 58:2696–2698.PubMedGoogle Scholar
  66. 66.
    Steinbakk, M., Naess-Andresen, C.-E, Lingaas, E., Dale, I., Brandtzaeg, P., and Fagerhol, M. K., 1990, Antimicrobial actions of calcium binding leucocyte Ll protein, calprotectin, Lancet 336:763–765.PubMedCrossRefGoogle Scholar
  67. 67.
    Knight, L., and Fletcher, J., 1971, Growth of Candida albicans in saliva; stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus, J. Infect. Dis. 123: 371–377.PubMedCrossRefGoogle Scholar
  68. 68.
    Epstein, J. B., Truelove, E. L., and Izutzu, K. T., 1984, Oral candidiasis: pathogenesis and host defense, Rev. Infect. Dis. 6:96–106.PubMedCrossRefGoogle Scholar
  69. 69.
    Fisker, A. V., Schiott, C. R., and Philipsen, H. P., 1982, Short-term oral candidosis in rats, with special reference to the site of infection, Acta Pathol. Microbiol. Immunol. Scand. B 90: 49–57.PubMedGoogle Scholar
  70. 70.
    Russell, C., Jones, J. H., and Gibbs, A. C. C., 1976, The carriage of Candida albicans in the mouths of rats treated with tetracycline briefly or for a prolonged period, Mycopathologia 58:125–129.PubMedCrossRefGoogle Scholar
  71. 71.
    DeMaria, A., Buckley, H., and von Lichtenberg, E, 1976, Gastrointestinal candidiasis in rats treated with antibiotics, cortisone and azathioprine, Infect. Immun. 13:1761–1770.PubMedGoogle Scholar
  72. 72.
    Cantorna, M. T., and Balish, E., 1990, Mucosal and systemic candidiasis in congenitally immunodeficient mice, Infect. Immun. 58:1093–1100.PubMedGoogle Scholar
  73. 73.
    Ouellette, A. J., Greco, R. M., James, M., Frederick, D., Naftilan, J., and Fallon, J. T., 1989, Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium, J. Cell Biol. 108:1687–1695.PubMedCrossRefGoogle Scholar
  74. 74.
    Selsted, M. E., Szklarek, D., Ganz, T., and Lehrer, R. I., 1985, Activity of rabbit leukocyte peptides against Candida albicans,Infect. Immun. 49:202–206.PubMedGoogle Scholar
  75. 75.
    Krause, W, Matheis, H., and Wulf, K., 1969, Fungaemia and funguria after oral administration of Candida albicans,Lancet 1:598–599.PubMedCrossRefGoogle Scholar
  76. 76.
    Sass, W, Dreyer, H. P., Bockeler, W, Hamelmann, H., and Seifert, J., 1987, Prinzipien der partikelresorption im magen-darm-trakt, Z. Gastroenterol. 25:306–315.PubMedGoogle Scholar
  77. 77.
    Baine, W. B., Koenig, M. G., and Goodman, J. S., 1974, Clearance of Candida albicans from the bloodstream of rabbits, Infect. Immun. 10:1420–1425.PubMedGoogle Scholar
  78. 78.
    Bird, D. C., and Sheagren, J. N., 1970, Evaluation of reticuloendothelial system phagocytic activity during systemic Candida albicans infection in mice, Proc. Soc. Exp. Biol. Med. 133:34–37.PubMedCrossRefGoogle Scholar
  79. 79.
    Cho, Y. S., and Choi, H. Y., 1979, Opportunistic fungal infection among cancer patients: a ten year autopsy study, Am. J. Clin. Pathol. 72:617–620.PubMedGoogle Scholar
  80. 80.
    Bach, M. C., Sahyoun, A., Adler, J. L., Schlesinger, R. M., Breman, J., Madras, P., P’eng, E K., and Monaco, A. P., 1973, High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression, Transplant. Proc. 5:549–553.PubMedGoogle Scholar
  81. 81.
    Louria, D. B., Brayton, R. G., and Finkel, G., 1963, Studies on the pathogenesis of experimental Candida albicans infections in mice, Sabouraudia 2:271–283.CrossRefGoogle Scholar
  82. 82.
    Ruthe, R. C., Andersen, B. R., Cunningham, B. L., and Epstein, R. B., 1978, Efficacy of granulocyte transfusions in control of systemic candidiasis in leukopenic host, Blood 52: 493–498.PubMedGoogle Scholar
  83. 83.
    Hurtrel, B., Lagrange, P. H., and Michel, J.-C.,1980, Systemic candidiasis in mice. II. Main role of polymorphonuclear leukocytes in resistance to infection, Ann. D’Immunol. 131:105–118.Google Scholar
  84. 84.
    Cutler, J. E., and Poor, A. H., 1981, Effect of mouse phagocytes on Candida albicans in in vivo chambers, Infect. Immun. 31:1110–1116.PubMedGoogle Scholar
  85. 85.
    Lehrer, R. I., and Cline, M. J., 1969, Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection, J Clin. Invest. 48:1478–1488.PubMedCrossRefGoogle Scholar
  86. 86.
    Cech, P., Papathanassiou, A., Boreux, G., Roth, P., and Miescher, P. A., 1979, Hereditary myeloperoxidase deficiency, Blood 53:403–411.PubMedGoogle Scholar
  87. 87.
    Cech, P., Stalder, H., Widmann, J.J., Rohner, A., and Miescher, P. A., 1979, Leukocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess, Am. J. Med. 66:149–153.PubMedCrossRefGoogle Scholar
  88. 88.
    Moosman, K., and Bojanovsky, A., 1975, Rezidivierende candidosis bei myeloperoxydase mangel, Monatschr. Kinderheilkd. 123:408–409.Google Scholar
  89. 89.
    Parry, M. E, Root, R. K., Metcalf, J. A., Delaney, K. K., Kaplow, L. S., and Richar, W. J., 1981, Myeloperoxidase deficiency. Prevalence and clinical significance, Ann. Intern. Med. 95: 293–301.PubMedCrossRefGoogle Scholar
  90. 90.
    Catovsky, D., Galton, D. A., Robinson, J., 1972, Myeloperoxidase-deficient neutrophils in acute myeloid leukaemia, Scand. J. Haematol. 9:142–148.PubMedCrossRefGoogle Scholar
  91. 91.
    Bendix-Hansen, K., and Nielsen, H. K., 1983, Myeloperoxidase-deficient polymorphonuclear leucocytes (II). Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse, Scand. J Haematol. 31:5–8.PubMedCrossRefGoogle Scholar
  92. 92.
    Bendix-Hansen, K., Kerndrup, G., and Pedersen, B., 1986, Myeloperoxidase-deficient polymorphonuclear leucocytes (VI): Relation to cytogenetic abnormalities in primary myelodysplastic syndromes, Scand. J. Haematol. 36:3–7.PubMedCrossRefGoogle Scholar
  93. 93.
    Lehrer, R. I., Goldberg, L. S., Apple, M. A., and Rosenthal, N. P., 1972, Refractory megaloblastic anemia with myeloperoxidase-deficient neutrophils, Ann. Intern. Med. 76: 447–453.PubMedCrossRefGoogle Scholar
  94. 94.
    Lehrer, R. I., 1972, Functional aspects of a second mechanism of candidacidal activity by human neutrophils, J. Clin. Invest. 51:2566–2572.PubMedCrossRefGoogle Scholar
  95. 95.
    Lehrer, R. I., Hanifin, J., and Cline, M. J., 1969, Defective bactericidal activity in myeloperoxidase-deficient human neutrophils, Nature (Lond.) 223:78–79.CrossRefGoogle Scholar
  96. 96.
    Lehrer, R. I., 1975, The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms, J. Clin. Invest. 55:338–346.PubMedCrossRefGoogle Scholar
  97. 97.
    Diamond, R. D., Krzesicki, R., and Jao, W, 1978, Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro, J Clin. Invest. 61:349–359.PubMedCrossRefGoogle Scholar
  98. 98.
    Rosner, E, Valmont, I., Kozinn, P. J., and Caroline, L., 1970, Leukocyte function in patients with leukemia, Cancer 25:835–842.PubMedCrossRefGoogle Scholar
  99. 99.
    Lehrer, R. I., and Cline, M. J., 1971, Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer, Cancer 27:1211–1217.PubMedCrossRefGoogle Scholar
  100. 100.
    Goldman, J. M., and Th’ng, K. H., 1973, Phagocytic function of leukocytes from patients with acute myeloid and chronic granulocytic leukaemia, Br. J. Haematol. 25:299–308.PubMedCrossRefGoogle Scholar
  101. 101.
    Bjerknes, R., Vindenes, H., and Laerum, O. D., 1990, Altered neutrophil functions in patients with large burns, Blood Cells 16:127–141.PubMedGoogle Scholar
  102. 102.
    El-Maalem, H., and Fletcher, J., 1976, Defective neutrophil function in chronic granulocytic leukaemia, Br. J. Haematol. 66:95–103.CrossRefGoogle Scholar
  103. 103.
    Child, J. A., Martin, S., Cawley, J. C., and Ghoniem, A. T. M., 1978, Defective microbicidal function of neutrophils in haematological malignancies and lymphomas: correction by levamisole in vitro, Biomedicine 29:159–161.PubMedGoogle Scholar
  104. 104.
    Uberti-Foppa, C., Franzetti, F., Hegri, C., Novati, R., Cinque, P., Privitera, G., Parente, E, Crocchiolo, P., and Lazzarin, A., 1987, Role of PMN’s candidacidal activity in the pathogenesis of AIDS-related systemic candidiasis, Bull. Ist. Sieroter. Milan 66:471–478.Google Scholar
  105. 105.
    Xanthou, M., Valassi-Adam, E., Kintsonidou, E., and Matsaniotis, N., 1975, Phagocytosis and killing ability of Candida albicans by blood leucocytes of healthy term and preterm babies, Arch. Dis. Child 50:72–75.PubMedCrossRefGoogle Scholar
  106. 106.
    Quie, P. G., and Chilgren, R. A., 1971, Acute disseminated and chronic mucocutaneous candidiasis, Semin. Hematol. 8:227–242.Google Scholar
  107. 107.
    Oseas, R., and Lehrer, R. I., 1978, A micromethod for measuring neutrophil candidacidal activity in neonates, Pediatr. Res. 12:828–829.PubMedCrossRefGoogle Scholar
  108. 108.
    Tuck, R., Burke, V., Gracey, M., Malajczuk, A., and Sunoto, 1979, Defective Candida killing in childhood malnutrition, Arch. Dis. Child. 54:445–447.PubMedCrossRefGoogle Scholar
  109. 109.
    Boyne, R., Arthur, J. R., and Wilson, A. B., 1986, An in vivo and in vitro study of selenium deficiency and infection in rats, J. Comp. Pathol. 96:379–386.PubMedCrossRefGoogle Scholar
  110. 110.
    Kernbaum, S., and Vilde, J.-L., 1974, Etude du pouvoir candidacide des polynucleaires neutrophiles humains, Pathol. Biol. (Paris) 22:61–66.Google Scholar
  111. 111.
    El Falaky, I. H., and Shoukry, H. M., 1977, Phagocytosis and intracellular killing of Candida albicans by polymorphonuclear leucocytes in thalassaemia, J. Egyptian Public Health Assoc. 52:317–329.Google Scholar
  112. 112.
    Drutz, D. J., and Lehrer, R. I., 1978, Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function, Am. J. Med. Sci. 276:77–92.PubMedGoogle Scholar
  113. 113.
    Edwards, J. E., Jr., Rotrosen, D., Fontaine, J. W, Haudenschild, C. C., and Diamond, R. D., 1987, Neutrophil-mediated protection of cultured human vascular endothelial cells from damage by growing Candida albicans hyphae, Blood 69:1450–1457.PubMedGoogle Scholar
  114. 114.
    Retrosen, D., Edwards, J. E., Jr., Gibson, T. R., Moore, J. C., Cohen, A. H., and Green, I., 1985, Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration, J. Infect. Dis. 152:1264–1274.CrossRefGoogle Scholar
  115. 115.
    Davies, R. R., and Denning, T. J. V., 1972, Candida albicans and the fungicidal activity of the blood, Sabouraudia 10:301–312.PubMedCrossRefGoogle Scholar
  116. 116.
    Lehrer, R. I., and Cline, M. J., 1969, Interaction of Candida albicans with human leukocytes and serum, J. Bacteriol. 98:996–1004.PubMedGoogle Scholar
  117. 117.
    Edwards, J. E., Jr., Lehrer, R. I., Stiehm, E. R., Fischer, T. J., and Young, L. S., 1978, Severe candidal infections. Clinical perspective, immune defense mechanisms, and current concepts of therapy, Ann. Intern. Med. 89:91–106.PubMedCrossRefGoogle Scholar
  118. 118.
    Ray, T. L., and Wuepper, K. D., 1976, Activation of the alternative (properdin) pathway of complement by Candida albicans and related species, J. Invest. Derm. 67:700–703.PubMedCrossRefGoogle Scholar
  119. 119.
    Denning, T. J. V., and Davies, R. R., 1973, Candida albicans and the chemotaxis of polymorphonuclear neutrophils, Sabouraudia 11:210–221.PubMedCrossRefGoogle Scholar
  120. 120.
    Weeks, B. A., Escobar, M. R., Hamilton, P. B., and Fueston, V. M., 1976, Chemotaxis of polymorphonuclear neutrophilic leukocytes by mannan-enriched preparations of Candida albicans, Adv. Exp. Med. Biol. 73:161–169.PubMedCrossRefGoogle Scholar
  121. 121.
    Ray, T. L., Hanson, A., Ray, L. E, and Wuepper, K. D., 1979, Purification of a mannan from Candida albicans which activates serum complement, J. Invest. Dermatol. 73:269–274.PubMedCrossRefGoogle Scholar
  122. 122.
    Cutler, J. E., 1977, Chemotactic factor produced by Candida albicans, Infect. Immun. 18: 568–573.PubMedGoogle Scholar
  123. 123.
    Morelli, R., and Rosenberg, L. T., 1971, The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes, J. Immunol. 107:476–480.PubMedGoogle Scholar
  124. 124.
    Yamamura, M., and Valdimarsson, H., 1977, Participation of C3 in intracellular killing of Candida albicans, Scand. J Immunol. 6:591–594.PubMedCrossRefGoogle Scholar
  125. 125.
    Ferrante, A., and Thong, Y. H., 1979, Requirement of heat-labile opsonins for maximal phagocytosis of Candida albicans, Sabouraudia 17:293–297.PubMedCrossRefGoogle Scholar
  126. 126.
    Kernbaum, S., 1975, Pouvoirs phagocytaire et fongicide envers Candida albicans des polynucleaires neutrophiles humains en presence de serum depourvu de C3 et C4, Ann. Microbiol. (Inst. Pasteur). 126A:75–81.Google Scholar
  127. 127.
    Morrison, R. P., and Cutler, J. E., 1981, In vitro studies of the interaction of murine phagocytic cells with Candida albicans, J. Reticuloendothel. Soc. 29:23–24.PubMedGoogle Scholar
  128. 128.
    Sinski, J. T., Reed, G. L., Kelley, L. M., and Le Vebvre, R., 1973, Macrophage migration technique using coccidioidin, Infect. Immun. 7:226–230.PubMedGoogle Scholar
  129. 129.
    Solomkin, J. S., Mills, E. L., Giebink, G. S., Nelson, R. D., Simmons, R. L., and Quie, P. G., 1978, Phagocytosis of Candida albicans by human leukocytes: opsonic requirements, J. Infect. Dis. 137:30–37.PubMedCrossRefGoogle Scholar
  130. 130.
    Leijh, P. C., Barselaar, M. T., and van Furth, R., 1977, Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes, Infect. Immun. 17:313–318.PubMedGoogle Scholar
  131. 131.
    Ginsburg, I., Sela, M. N., Morag, A., Ravid, Z., Duchan, Z., Ferne, M., Rabinowitz-Bergner, S., Thomas, P. R, Davies, R, Niccols, J., Humes, J., and Bonney, R., 1981, Role of leukocyte factors and cationic polyelectrolytes in phagocytosis of group A streptococci and Candida albicans by neutrophils, macrophages, fibroblasts and epithelial cells: modulation by anionic polyelectrolytes in relation to pathogenesis of chronic inflammation, Inflammation 5:289–312.PubMedCrossRefGoogle Scholar
  132. 132.
    Pereira, H. A., and Hosking, C. S., 1984, The role of complement and antibody in opsonization and intracellular killing of Candida albicans, Clin. Exp. Immunol. 57:307–314.PubMedGoogle Scholar
  133. 133.
    Sandhu, D. K., Sandhu, R. S., Damodaran, V. N., and Randhawa, H. S., 1970, Effect of cortisone on bronchopulmonary aspergillosis in mice exposed to spores of various Aspergillus species, Sabouraudia 8:32–38.PubMedCrossRefGoogle Scholar
  134. 134.
    Hurley, D. L., Balow, J. E., and Fauci, A. S., 1975, Experimental disseminated candidiasis. II. Administration of glucocorticosteroids, susceptibility to infection and immunity, J Infect. Dis. 132:393–398.PubMedCrossRefGoogle Scholar
  135. 135.
    Laforce, E. M., Mills, D. M., Iverson, K., Cousins, R., and Everett, E. D., 1975, Inhibition of leukocyte candidacidal activity by serum from patients with disseminated candidiasis, J. Lab. Clin. Med. 86:657–666.PubMedGoogle Scholar
  136. 136.
    Walker, S. M., and Urbaniak, S. J., 1980, A serum-dependent defect of neutrophil function in chronic mucocutaneous candidiasis, J. Clin. Pathol. 33:370–372.PubMedCrossRefGoogle Scholar
  137. 137.
    Fleischmann, J., Selsted, M. E., and Lehrer, R. I., 1985, Opsonic activity of MCP-1 and MCP-2, cationic peptides from rabbit alveolar macrophages, Diagn. Microbiol. Infect. Dis. 3: 233–242.PubMedCrossRefGoogle Scholar
  138. 138.
    Hector, R. E, Domer, J. E., and Carrow, E. W, 1982, Immune responses to Candida albicans in genetically-distinct mice, Infect. Immun. 38:1020–1028.PubMedGoogle Scholar
  139. 139.
    Lyon, E. L., Hector, R. E, and Domer, J. E., 1986, Innate and acquired immune responses against Candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component, J. Med. Vet. Mycol. 24:359–367.PubMedCrossRefGoogle Scholar
  140. 140.
    Gelfand, J. A., Hurley, D. L., Fauci, A. S., and Frank, M. M., 1978, Role of complement in host defense against experimental disseminated candidiasis, J. Infect. Dis. 138:9–16.PubMedCrossRefGoogle Scholar
  141. 141.
    Lehrer, R. I., 1970, Measurement of candidacidal activity of specific leukocyte types in mixed cell populations. I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils, Infect. Immun. 2:42–47.PubMedGoogle Scholar
  142. 142.
    Husseini, R. H., Hoadley, M. E., Hutchinson, J. J. P., Penn, C. W, and Smith, H., 1985, Intracellular killing of Candida albicans by human polymorphonuclear leucocytes: comparison of three methods of assessment, J. Immunol. Methods 81:215–221.PubMedCrossRefGoogle Scholar
  143. 143.
    Lehrer, R. I., 1971, Inhibition by sulfonamides of the candidacidal activity of human neutrophils, J. Clin. Invest. 50:2498–2505.PubMedCrossRefGoogle Scholar
  144. 144.
    Schmid, L., and Brune, K., 1974, Assessment of phagocytic and antimicrobial activity of human granulocytes, Infect. Immun. 10:1120–1126.PubMedGoogle Scholar
  145. 145.
    Vecchiarelli, A., Bistoni, E, Cenci, E., Perito, S., and Cassone, A., 1985, In-vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity, Sabouraudia 23:377–387.PubMedCrossRefGoogle Scholar
  146. 146.
    Scherwitz, C., and Martin, R., 1979, The phagocytosis of Candida albicans blastospores and germ tubes by polymorphonuclear leukocytes, Dermatologia 159:12–23.CrossRefGoogle Scholar
  147. 147.
    Schuit, K. E., 1979, Phagocytosis and intracellular killing of pathogenic yeast by human monocytes and neutrophils, Infect. Immun. 24:932–938.PubMedGoogle Scholar
  148. 148.
    Cockayne, A., and Odds, E. C., 1984, Interactions of Candida albicans yeast cells, germ tubes, and hyphae with human polymorphonuclear leucocytes in vitro, j Gen. Microbiol. 130: 465–471.PubMedGoogle Scholar
  149. 149.
    Brummer, E., McEwen, J. G., and Stevens, D. A., 1986, Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: comparison with murine peripheral blood PMN, Clin. Exp. Immunol. 66:681–690.PubMedGoogle Scholar
  150. 150.
    Kernbaum, S., 1975, Pouvoir candidacide des polynucleaires neutrophiles humains et chimiotherapie antibacterienne, Pathol. Biol. 22:789–794.Google Scholar
  151. 151.
    Ferrari, E A., Pagani, A., Marconi, M., Stefanoni, R., and Siccardi, A. G., 1980, Inhibition of candidacidal activity of human neutrophil leukocytes by aminoglucoside antibiotics, Antimicrob. Agents Chemother. 17:87–88.PubMedCrossRefGoogle Scholar
  152. 152.
    Roilides E., Walsh, T. J., Rubin, M., Venzon, D., and Pizzo, P. A., 1990, Effects of antifungal agents on the function of human neutrophils in vitro, Antimicrob. Agents Chemother. 34: 196–201.PubMedCrossRefGoogle Scholar
  153. 153.
    Meshulam, T., Diamond, R. D., Lyman, C. A., Wysong, D. R., and Melnick, D. A., 1988, Temporal association of calcium mobilization, inositol triphosphate generation, and superoxide anion release by human neutrophils activated by serum opsonized and nonopsonized particulate stimuli, Biochem. Biophys. Res. Commun. 150:532–539.PubMedCrossRefGoogle Scholar
  154. 154.
    Wilson, R. M., and Reeves, W G., 1986, Neutrophil phagocytosis and killing in insulin-dependent diabetes, Clin. Exp. Immunol. 63:478–484.PubMedGoogle Scholar
  155. 155.
    Chan, C. K., and Balish, E., 1978, Inhibition of granulocyte phagocytosis of Candida albicans by amphotericin B, Can. J. Microbiol. 24:363–364.Google Scholar
  156. 156.
    Belches-, R. W, Carney, J. E, and Monahan, F. G., 1973, An electron microscopic study of phagocytosis of Candida albicans by polymorphonuclear leukocytes, Lab. Invest. 29: 620–627.Google Scholar
  157. 157.
    Richardson, M., and Smith, H., 1983, Ultrastructural features of phagocytosis and intracellular killing of Candida albicans by mouse polymorphonuclear phagocyte monolayers, Mycopathologia 83:97–102.PubMedCrossRefGoogle Scholar
  158. 158.
    Cech, P., and Lehrer, R. I., 1984, Heterogeneity of human neutrophil phagolysosomes: functional consequences for candidacidal activity, Blood 64:147–151.PubMedGoogle Scholar
  159. 159.
    Levitz, S. M., DiBenedetto, D. J., and Diamond, R. D., 1987, A rapid fluorescent assay to distinguish attached from phagocytized yeast particles, J. Immunol. Methods 101:37–42.PubMedCrossRefGoogle Scholar
  160. 160.
    Klebanoff, S. J., 1980, Oxygen metabolism and the toxic properties of phagocytes, Ann. Intern. Med. 93:480–489.PubMedCrossRefGoogle Scholar
  161. 161.
    Weiss, S. J., Test, S. T., Eckmann, C. M., Roos, D., and Regiani, S., 1986, Brominating oxidants generated by human eosinophils, Science 234:200–203.PubMedCrossRefGoogle Scholar
  162. 162.
    Lehrer, R. I., 1971, Measurement of candidacidal activity of specific leukocyte types in mixed cell populations: II. Normal and chronic granulomatous disease eosinophils, Infect. Immun. 3:800–802.PubMedGoogle Scholar
  163. 163.
    Foote, C. S., Goyne, T. E., and Lehrer, R. I., 1983, Assessment of chlorination by human neutrophils, Nature 301:715–716.PubMedCrossRefGoogle Scholar
  164. 164.
    Weiss, S. J., Klein, R., Slivka, A., and Wei, M., 1982, Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation, J. Clin. Invest. 70:598–607.PubMedCrossRefGoogle Scholar
  165. 165.
    Lehrer, R. I., 1969, Antifungal effects of peroxidase systems, J. Bacteriol. 99:361–365.PubMedGoogle Scholar
  166. 166.
    Lehrer, R. I., and Jan, R. G., 1970, Interaction of Aspergillus fumigatus spores with human leukocytes and serum, Infect. Immun. 1:345–350.PubMedGoogle Scholar
  167. 167.
    Diamond, R. D., Clark, R. A., and Haudenschild, C. C., 1980, Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro, J. Clin. Invest. 66:908–917.PubMedCrossRefGoogle Scholar
  168. 168.
    Wagner, D. K., Collins-Lech, C., and Sohnle, P. G., 1986, Inhibition of neutrophil killing of Candida albicans pseudohyphae by substances which quench hypochlorous acid and chlor-amines, Infect. Immun. 51:731–735.PubMedGoogle Scholar
  169. 169.
    Beilke, M. A., Collins-Lech, C., and Sohnle, P. G., 1989, Candidacidal activity of the neutrophil myeloperoxidase system can be protected from excess hydrogen peroxide by the presence of ammonium ion, Blood 73:1045–1049.PubMedGoogle Scholar
  170. 170.
    Kolotila, M. P., and Diamond, R. D., 1990, Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans W0–1, Infect. Immun. 58:1174–1179.PubMedGoogle Scholar
  171. 171.
    Babior, B. M., 1988, The respiratory burst oxidase, in, Phagocytic defects II (Curnutte, J. J., ed). Hematol. Oncol Clin. North Am. 2:201–212.PubMedGoogle Scholar
  172. 172.
    Clark, R. A., 1990, Perspective: The human neutrophil respiratory burst oxidase, J. Infect. Dis. 161:1140–1147.PubMedCrossRefGoogle Scholar
  173. 173.
    Cohen, M. S., Isturiz, R. E., Malech, H. L., Root, R. K., Wilfert, C. M., Gutman, L., and Buckley, R. H., 1981, Fungal infection in chronic granulomatous disease—the importance of the phagocyte in defense against fungi, Am. j Med. 71:59–66.PubMedCrossRefGoogle Scholar
  174. 174.
    Lehrer, R. I., Ladra, K. M., and Hake, R. B., 1975, Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbi;, and guinea pig leukocytes, Infect. Immun. 11:1226–1234.PubMedGoogle Scholar
  175. 175.
    Levitz, S. M., and Diamond, R. D., 1984, Killing of Aspergillus fumigates spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system, Infect. Immun. 43:1100–1102.PubMedGoogle Scholar
  176. 176.
    Lehrer, R. I., Szklarek, D., Ganz, T., and Selsted, M. E., 1985, Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity, Infect. Immun. 49: 207–211.PubMedGoogle Scholar
  177. 177.
    Lehrer, R. I., Szklarek, D., Ganz, T., and Selsted, M. E., 1986, Synergistic activity of rabbit granulocyte peptides against Candida albicans, Infect. Immun. 52:902–904.PubMedGoogle Scholar
  178. 178.
    Diamond, R. D., and Krzesicki, R., 1978, Mechanism of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro, J. Clin. Invest. 61:360–369.CrossRefGoogle Scholar
  179. 179.
    Levitz, S. M., Lyman, C. A., Murata, T., Sullivan, J. A., Mandell, G. L., and Diamond, R. D., 1987, Cytosolic calcium changes in individual neutrophils stimulated by opsonized and unopsonized Candida albicans hyphae, Infect. Immun. 55:2783–2788.PubMedGoogle Scholar
  180. 180.
    Lyman, C. A., Simons, E. R., Melnick, D. A., and Diamond, R. D., 1987, Unopsonized Candida albicans hyphae stimulate a neutrophil respiratory burst and a cytosolic calcium flux without membrane depolarization, j Infect. Dis. 156:770–776.PubMedCrossRefGoogle Scholar
  181. 181.
    Lyman, C. A., Simons, E. R., Melnick, D. A., and Diamond, R.D., 1988, Induction of signal transduction in human neutrophils by Candida albicans hyphae: the role of pertussis toxin-sensitive guanosine triphosphate-binding proteins, J. Infect. Dis. 158:1056–1064.PubMedCrossRefGoogle Scholar
  182. 182.
    Kolotila, M. R, and Diamond, R. D., 1988, Stimulation of neutrophil actin polymerization and degranulation by opsonized and unopsonized Candida albicans hyphae and zymosan, Infect. Immun. 56:2016–2022.PubMedGoogle Scholar
  183. 183.
    Wysong, D. R., Lyman, C. A., and Diamond, R. D., 1989, Independence of neutrophil respiratory burst oxidant generation from the early cytosolic calcium response after stimulation with unopsonized Candida albicans hyphae, Infect. Immun. 57:1499–1505.PubMedGoogle Scholar
  184. 184.
    Diamond, R. D., and Noble, L., 1990, Patterns of guanine nucleotide exchange reflecting disparate neutrophil activation pathways by opsonized and unopsonized Candida albicans hyphae, J. Infect. Dis. 162:262–265.PubMedCrossRefGoogle Scholar
  185. 185.
    Sawyer, D. W, Donowitz, G. R., and Mandell, G. L., 1989, Polymorphonuclear neutrophils: an effective antimicrobial force, Rev. Infect. Dis. 11:S1532–S1544.PubMedCrossRefGoogle Scholar
  186. 186.
    Lehrer, R. I., and Ganz, T., 1990, Antimicrobial polypeptides of human neutrophils, Blood 76:2169–2181.PubMedGoogle Scholar
  187. 187.
    Zeya, H. I., and Spitznagel, J. K., 1966, Cationic proteins of polymorphonuclear leukocyte lysosomes. I. Resolution of antibacterial and enzymatic activities, J. Bacteriol. 91:750–754.PubMedGoogle Scholar
  188. 188.
    Lehrer, R. I., Ganz, T., and Selsted, M. E., 1990, Defensins: natural peptide antibiotics from neutrophils, ASM News 56:315–318.Google Scholar
  189. 189.
    Ganz, T., Selsted, M. E., and Lehrer, R. I., 1990, Defensins, Bur. j Haematol. 44:1–8.Google Scholar
  190. 190.
    Lehrer, R. I., Ganz, T., Szklarek, D., and Selsted, M. E., 1988, Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations, J. Clin. Invest. 81:1829–1835.PubMedCrossRefGoogle Scholar
  191. 191.
    Rice, W. G., Ganz, T., Kinkade, J. M., Jr., Selsted, M. E., Lehrer, R. I., and Parmley, R. T., 1987, Defensin-rich dense granules of human neutrophils, Blood 70:757–765.PubMedGoogle Scholar
  192. 192.
    Wilde, C. G., Griffith, J. E., Marra, M. N., Snable, J. L., and Scott, R. W, 1989, Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family, J. Biol. Chem. 264:11200–11203.PubMedGoogle Scholar
  193. 193.
    Selsted, M. E., Brown, D. M., DeLange, R. J., Harwig, S. S., and Lehrer, R. I., 1985, Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils, J. Biol. Chem. 260: 4579–4584.PubMedGoogle Scholar
  194. 194.
    Eisenhauer, P. B., Harwig, S. S. L., Szklarek, D., Ganz, T., Selsted, M. E., and Lehrer, R. I., 1989, Purification and antimicrobial properties of three defensins from rat neutrophils, Infect. Immun. 57:2021–2027.PubMedGoogle Scholar
  195. 195.
    Eisenhauer, P., Harwig, S. S. S. L., Szklarek, D., Ganz, T., and Lehrer, R. I., 1990, Polymorphic expression of defensins in neutrophils from outbred rats, Infect. Immun. 58: 3899–3902.PubMedGoogle Scholar
  196. 196.
    Kagan, B. L., Selsted, M. E., Ganz, T., and Lehrer, R. I., 1990, Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes, Proc. Natl. Acad. Sci. USA 87:210–214.PubMedCrossRefGoogle Scholar
  197. 197.
    Odeberg, H., and Olsson, I., 1975, Antibacterial activity of cationic proteins from human granulocytes, J. Clin. Invest. 56:1118–1124.PubMedCrossRefGoogle Scholar
  198. 198.
    Odeberg, H., and Olsson, I., 1976, Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein, Infect. Immun. 14:1276–1283.PubMedGoogle Scholar
  199. 199.
    Gabay, J. E., Scott, R. W, Campanelli, D., Griffith, J., Wilde, C., 1989, Antibiotic proteins of human polymorphonuclear leukocytes, Proc. Natl. Acad. Sci. USA 86:5610–5614.PubMedCrossRefGoogle Scholar
  200. 200.
    Campanelli, D., Detmers, P. A., Nathan, C. E, Gabay, J. E., 1990, Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties, J. Clin. Invest. 85;904–915.PubMedCrossRefGoogle Scholar
  201. 201.
    Wilde, C. G., Snable, J. L., Griffith, J. E., Scott, R. W, 1990, Characterization of two azurophil granule proteases with active-site homology to neutrophil elastase, J. Biol. Chem. 265:2038–2041.PubMedGoogle Scholar
  202. 202.
    Shafer, W. M., Pohl, J., Onunka, V. C., Bangalore, N., and Travis, J., 1990, Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide, J. Biol. Chem. 266:112–116.Google Scholar
  203. 203.
    Arnold, R. R., Brewer, M., and Gauthier, J. J., 1980, Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms, Infect. Immun. 28:893–898.PubMedGoogle Scholar
  204. 204.
    Collins, M. S., and Pappagianis, D., 1973, Effects of lysozyme and chitinase on the spherules of Coccidioides immitis in vitro, Infect. Immun. 7:817–822.PubMedGoogle Scholar
  205. 205.
    Gadebusch, H. H., and Johnson, A. G., 1966, Natural host resistance to infection with Cryptococcus neoformans. IV. The effect of some cationic proteins on the experimental disease, J. Infect. Dis. 116:551–565.PubMedCrossRefGoogle Scholar
  206. 206.
    Rausch, P. G., and Moore, T. G., 1975, Granule enzymes of polymorphonuclear neutrophils: a phylogenetic comparison, Blood 46:913–919.PubMedGoogle Scholar
  207. 207.
    Marquis, G., Montplaisir, S., Garzon, S., Strykowski, H., and Auger, P., 1982, Fungitoxicity of muraminidase: ultrastructural damage to Candida albicans, Lab. Invest. 46:627–636.PubMedGoogle Scholar
  208. 208.
    Kamaya, T., 1970, Lytic action of lysozyme on Candida albicans, Mycopathol. Mycol. Appl. 42: 197–207.PubMedCrossRefGoogle Scholar
  209. 209.
    Ray, T. L., and Wuepper, K. D., 1976, Experimental cutaneous candidiasis in rodents, J. Invest. Derm. 66:29–33.PubMedCrossRefGoogle Scholar
  210. 210.
    Ray, T. L., and Wuepper, K. D., 1978, Experimental cutaneous candidiasis in rodents II. Role of the stratum corneum barrier and serum complement as a mediator of a protective inflammatory response, Arch. Dermatol. 114:539–543.PubMedCrossRefGoogle Scholar
  211. 211.
    Louria, D. B., and Brayton, R. G., 1964, Behavior of Candida cells within leukocytes, Proc. Soc. Exp. Biol. Med. 115:93–98.PubMedCrossRefGoogle Scholar
  212. 212.
    Diamond, R. D., Oppenheim, E, Nakagawa, Y., Krzesicki, R., and Haudenschild, C. C., 1980, Properties of a product of Candida albicans hyphae and pseudohyphae that inhibits contact between the fungi and human neutrophils in vitro, J. Immunol. 125:2797–2804.PubMedGoogle Scholar
  213. 213.
    Smail, E. H., Melnick, D. A., Ruggeri, R., and Diamond, R. D., 1988, A novel natural inhibitor from Candida albicans hyphae causing dissociation of the neutrophil respiratory burst response to chemotactic peptides from other post-activating events, J. Immunol. 140: 3893–3899.PubMedGoogle Scholar
  214. 214.
    Smail, E. H., Kolotila, M. P., Ruggeri, R., and Diamond, R. D., 1989, Natural inhibitor from Candida albicans blocks release of azurophil and specific granule contents by chemotactic peptide-stimulated human neutrophils, Infect. Immun. 57:689–692.PubMedGoogle Scholar
  215. 215.
    Hilger, A. E., and Danley, D. L., 1980, Alteration of polymorphonuclear leukocyte activity by viable Candida albicans, Infect. Immun. 27:714–720.PubMedGoogle Scholar
  216. 216.
    Danley, D. L., Hilger, A. E., Winkel, C. A., 1983, Generation of hydrogen peroxide by Candida albicans and influence on murine polymorphonuclear leukocyte activity, Infect. Immun. 40:97–102.Google Scholar
  217. 217.
    Heidenreich, E, and Dierich, M. P., 1985, Candida albicans and Candida stellatoidea in contrast to other Candida species bind iC3b and C3d but not C3b, Infect. Immun. 50:598–600.PubMedGoogle Scholar
  218. 218.
    Edwards, J. E., Jr., Gaither, T. A., O’Shea, J. J., Rotrosen, D., Lawley, T. J., Wright, S. A., Frank, M. M., and Green, I., 1986, Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors, J. Immunol. 137: 3577–3583.PubMedGoogle Scholar
  219. 219.
    Calderone, R. A., Linehan, L., Wadsworth, E., and Sandberg, A. L., 1988, Identification of C3d receptors on Candida albicans, Infect. Immun. 56:252–258.PubMedGoogle Scholar
  220. 220.
    Gilmore, B. J., Retsinas, E. M., Lorenz, J. S., and Hostetter, M. K., 1988, An iC3b receptor on Candida albicans: structure, function and correlates for pathogenicity, J Infect. Dis. 157: 38–46.PubMedCrossRefGoogle Scholar
  221. 221.
    Eigentler, A., Schulz, T. E, Larcher, C., Breitwieser, E. M., Myones, B. L., Petzer, A. L., and Dierich, M. P., 1989, C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3, Infect. Immun. 57: 616–622.PubMedGoogle Scholar
  222. 222.
    Hostetter, M. K., 1990, Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans, Diabetes 39:271–275.PubMedCrossRefGoogle Scholar
  223. 223.
    Hostetter, M. K., Lorenz, J. S., Preus, L., Kendrick, K. E., 1990, The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose, J. Infect. Dis. 161:761–768.PubMedCrossRefGoogle Scholar
  224. 224.
    Slutsky, B., Buffo, J., and Soll, D. R., 1985, High-frequency switching of colony morphology in Candida albicans, Science 230:666–669.PubMedCrossRefGoogle Scholar
  225. 225.
    Soll, D. R., Slutsky, B., Mackenzie, S., Langtimm, C., and Staebell, M., 1987, Two newly discovered switching systems in Candida albicans and their possible role in oral candidiasis, in: Oral mucosal diseases: biology, etiology, and therapy,(I. C. Mackenzie, C. A. Squier, and E. Dabelsteen, eds.), Laegeforeningen Forlag, Copenhagen, pp. 52–59.Google Scholar
  226. 226.
    Ishikawa, T., Dalton, A. C., and Arbesman, C. E., 1972, Phagocytosis of Candida albicans by eosinophilic leukocytes, j Allergy Clin. Immunol. 49:311–315.PubMedCrossRefGoogle Scholar
  227. 227.
    Ishikawa, T., Yu, M. C., and Arbesman, C. E., 1972, Electron microscopic demonstration of phagocytosis of Candida albicans by human eosinophilic leukocytes, J. Allergy Clin. Immunol. 50:183–187.PubMedCrossRefGoogle Scholar
  228. 228.
    Lehrer, R. I., 1981, Ingestion and destruction of Candida albicans, in: Methods for Studying Mononuclear Phagocytes, (D. A. Adams, H. Koren, and P. Edelson, eds.), Academic, New York, pp. 693–708.CrossRefGoogle Scholar
  229. 229.
    Estevez, M. E., Sen, L., Vadez, R., and Balina, L. M., 1979, Defective blood mononuclear phagocyte function in patients with leprosy, Int. j Leprosy 47:575–579.Google Scholar
  230. 230.
    Estevez, M. E., Ballart, I. J., Diez, R. A., Planes, N., Scaglione, C., and Sen, L., 1986, Early defect of phagocytic cell function in subjects at risk for acquired immunodeficiency syndrome, Scand. J Immunol. 24:215–221.PubMedCrossRefGoogle Scholar
  231. 231.
    Cohen, A. B., and Cline, M. J., 1971, The human alveolar macrophage: isolation, cultivation in vitro and studies of morphologic and functional characteristics, J. Clin. Invest. 50:1390–1398.PubMedCrossRefGoogle Scholar
  232. 232.
    Kemmerich, B., Rossing, T. H., and Pennington, J. E., 1987, Comparative oxidative microbicidal activity of human blood monocytes and alveolar macrophages and activation by recombinant gamma interferon, Am. Rev. Respir. Dis. 136:266–270.PubMedCrossRefGoogle Scholar
  233. 233.
    Territo, M. C., and Golde, D. W, 1979, The function of human alveolar macrophages, J. Reticuloendothel. Soc. 25:111–120.PubMedGoogle Scholar
  234. 234.
    Winston, D. J., Territo, M. C., Ho, W. G., Miller, M. J., Gale, R. P., and Golde, D. W, 1982, Alveolar macrophage dysfunction in human bone marrow transplant recipients, Am. J. Med. 73:859–866.PubMedCrossRefGoogle Scholar
  235. 235.
    Golde, D. W, Territo, M., Finley, T. N., and Cline, M. J., 1976, Defective lung macrophages in pulmonary alveolar proteinasis, Ann. Intern. Med. 85:304–309.PubMedCrossRefGoogle Scholar
  236. 236.
    Robinson, J. E., Harvey, B. A. M., and Soothill, J. E, 1978, Phagocytosis and killing of bacteria and yeast by human milk cells after opsonisation in aqueous phase of milk, Br. Med. J. 1:1443–1445.PubMedCrossRefGoogle Scholar
  237. 237.
    Taschdjian, C. L., Toni, E. E, Hsu, K. C., Seelig, M. S., Cuesta, M. B., and Kozinn, P. J., 1971, Immunofluorescence studies of Candida in human reticuloendothelial phagocytes: implications for immunogenesis and pathogenesis of systemic candidiasis, Am. J. Clin. Pathol. 56: 50–58.PubMedGoogle Scholar
  238. 238.
    Odegaard, A., Viken, K. E., and Lamvik, J., 1974, Structural and functional properties of blood monocytes cultured in vitro, Acta Pathol. Microbiol. Scand. Sect. G. 82:223–234.Google Scholar
  239. 239.
    Lehrer, R. I., 1970, The fungicidal activity of human monocytes: a myeloperoxidase-linked mechanism, Clin. Res. 18:408–413.Google Scholar
  240. 240.
    Sasada, M., Kubo, A., Nishimura, T., Kakita, T., Moriguchi, T., Yamamoto, K., and Uchino, H., 1987, Candidacidal activity of monocyte-derived human macrophages: relationship between Candida killing and oxygen radical generation by human macrophages, J. Leukoc. Biol. 41:289–294.PubMedGoogle Scholar
  241. 241.
    Bourne, H. R., Lehrer, R. I., Cline, M. J., and Melmon, K. L., 1971, Cyclic 3’,5’-adenosine monophosphate in the human leukocyte: synthesis, degradation, and effects on neutrophil candidacidal activity, j Clin. Invest. 50:920–929.PubMedCrossRefGoogle Scholar
  242. 242.
    Odegaard, A., and Lamvik, J., 1976, The effect of phenylbutazone and chloramphenicol on phagocytosis of radiolabelled Candida albicans by human monocytes cultured in vitro, Acta Pathol. Microbiol. Scand. Sect. C 84:37–44.Google Scholar
  243. 243.
    Louria, D. B., Fallon, N., and Browne, H. G., 1960, The influence of cortisone on experimental fungus infections in mice, J. Clin. Invest. 39:1435–1449.PubMedCrossRefGoogle Scholar
  244. 244.
    Diamond, R. D., 1981, Mechanisms of host resistance to Candida albicans. In Microbiology 1981, American Society for Microbiology, Washington, D. C., pp. 200–204.Google Scholar
  245. 245.
    Rinehart, J. J., Sagone, A. L., Balcerzak, S. P., Ackerman, G. A., and LoBuglio, A. E, 1975, Effects of corticosteroid therapy on human monocyte function, N. Engl. J Med. 292:236–241.PubMedCrossRefGoogle Scholar
  246. 246.
    Hammerstrom, J., and Unsgaard, G., 1979, In vitro influence of endotoxin on human mononuclear phagocyte structure and function, Acta Pathol. Microbiol. Scand. Sect. C 87: 381–389.Google Scholar
  247. 247.
    Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S. L., Daher, K., Bainton, D. E, and Lehrer, R. I., 1985, Defensins: natural peptide antibiotics of human neutrophils, J. Clin. Invest. 76: 1427–1435.PubMedCrossRefGoogle Scholar
  248. 248.
    Campbell, E. J., Silverman, E. K., and Campbell, M. A., 1989, Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli and heterogeneity in elastase-mediated proteolytic activity, J. Immunol. 143:2961–2968.PubMedGoogle Scholar
  249. 249.
    Hurtrel, B., and Lagrange, P. H., 1981, Comparative effects of carrageenan on systemic candidiasis and listeriosis in mice, Clin. Exp. Immunol. 44:355–358.PubMedGoogle Scholar
  250. 250.
    Lee, K. W, and Balish, E., 1983, Systemic candidosis in silica-treated athymic and euthymic mice, Infect. Immun. 41:902–907.PubMedGoogle Scholar
  251. 251.
    Sinha, B. K., Monga, D. P., and Prasad, S., 1987, Studies of the role of macrophages in experimental candidosis in mice, Mykosen 30:105–112.PubMedCrossRefGoogle Scholar
  252. 252.
    Baghian, A., and Lee, K. W, 1988, Role of activated macrophages in resistance to systemic candidosis, J. Leukoc. Biol. 44:166–171.PubMedGoogle Scholar
  253. 253.
    Cheers, C., and Waller, R., 1975, Activated macrophages in congenitally athymic “nude” mice and in lethally irradiated mice, J Immunol. 115:844–847.PubMedGoogle Scholar
  254. 254.
    Cutler, J. E., 1976, Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice, J. Reticuloendothel. Soc. 19:121–124.PubMedGoogle Scholar
  255. 255.
    Poor, A. H., and Cutler, J.E., 1981, Analysis of an in vivo model to study the interaction of host factors with Candida albicans, Infect. Immun. 31:1104–1109.Google Scholar
  256. 256.
    Bistoni, E, Vecchiarelli, A., Cenci, E., Puccetti, P., Marconi, P., and Cassone, A., 1986, Evidence for macrophage-mediated protection against lethal Candida albicans infection, Infect. Immun. 51:668–674.PubMedGoogle Scholar
  257. 257.
    Chow, H. S., Sarpel, S. C., and Epstein, R. B., 1980, Pathophysiology of Candida albicans meningitis in normal, neutropenic and granulocyte transfused dogs, Blood 55:546–551.PubMedGoogle Scholar
  258. 258.
    Bistoni, E, Baccarini, M., Blasi, E., Marconi, P., Puccetti, P., and Garaci, E., 1983, Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice, Infect. Immun. 40:46–55.PubMedGoogle Scholar
  259. 259.
    Fromtling, R. A., Abruzzo, G. K., and Giltinan, D. M., 1987, Candida tropicales infection in normal, diabetic, and neutropenic mice, J. Clin. Microbiol. 25:1416–1420.Google Scholar
  260. 260.
    van’t Wout, J. W, Linde, I., Leijh, P. C. J., and van Furth, R., 1988, Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection, Eur. J. Clin. Microbiol. Infect. Dis. 7:736–741.CrossRefGoogle Scholar
  261. 261.
    Sawyer, R. T., and Harmsen, A. G., 1989, The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans, Mycopathologia 108:95–105.Google Scholar
  262. 262.
    Oblack, D. L., Schwarz, J., and Holder, I. A., 1979, Enhancement of tissue damage by Candida albicans in cortisone or nitrogen mustard-treated mice, Can. J Microbiol. 25:1015–1020.PubMedCrossRefGoogle Scholar
  263. 263.
    Nugent, K. M., and Onofrio, J. M., 1984, Pulmonary clearance of Candida albicans in neutropenic mice, J. Infect. Dis. 149:1020.PubMedCrossRefGoogle Scholar
  264. 264.
    Hasenclever, H. E, and Corley, E. J., 1968, Enhancement of acquired resistance in murine candidiasis by Bordetella pertussis vaccine, Sabouraudia 6:289–295.PubMedCrossRefGoogle Scholar
  265. 265.
    Marra, S., and Balish, E., 1974, Immunity to Candida albicans induced by Listeria monocytogenes, Infect. Immun. 10:72–82.PubMedGoogle Scholar
  266. 266.
    Sher, N. A., Chaparas, S. D., Greenberg, L. E., and Bernard, S., 1975, Effects of BCG, Corynebacterium parvum and methanol-extraction residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infection in immunosuppressed mice, Infect. Immun. 12:1325–1330.PubMedGoogle Scholar
  267. 267.
    Rogers, T. J., and Balish, E., 1977, The role of activated macrophages in resistance to experimental renal candidiasis, J. Reticuloendothel. Soc. 22:309–318.PubMedGoogle Scholar
  268. 268.
    Sawyer, R. T., Moon, R. J., and Beneke, E. S., 1981, Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers, Infect. Immun. 32:945–950.PubMedGoogle Scholar
  269. 269.
    Cummings, N. P., Pabst, M. J., and Johnston, R. B., Jr., 1980, Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide, j Exp. Med. 152:1659–1669.PubMedCrossRefGoogle Scholar
  270. 270.
    Fraser-Smith, E. B., Waters, R. V., and Matthews, T. R., 1982, Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice, Infect. Immun. 35:105–110.PubMedGoogle Scholar
  271. 271.
    Fraser-Smith, E. B., Eppstein, D. A., Larsen, M. A., and Matthews, T. R., 1983, Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infection, Infect. Immun. 39:172–178.PubMedGoogle Scholar
  272. 272.
    Baccarini, M., Blasi, E., Puccetti, P., and Bistoni, E, 1983, Phagocytic killing of Candida albicans by different murine effector cells, Sabouraudia 21:271–286.PubMedCrossRefGoogle Scholar
  273. 273.
    Baccarini, M., Bistoni, E, and Lohmann-Matthes, M. L., 1986, Organ-associated macrophage precursor activity: isolation of candidacidal and tumoricidal effectors from the spleens of cyclophosphamide-treated mice, J. Immunol. 136:837–843.PubMedGoogle Scholar
  274. 274.
    Decker, T., Baccarini, M., and Lohmann-Matthes, M. L., 1986, Liver-associated macrophage precursors as natural cytotoxic effectors against Candida albicans and Yac-1 cells, Eur. j Immunol. 16:693–699.PubMedCrossRefGoogle Scholar
  275. 275.
    Baccarini, M., Bistoni, E, and Lohmann-Matthes, M.-L., 1985, In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells, j Immunol. 134:2658–2665.Google Scholar
  276. 276.
    Decker, T, Lohmann-Matthes, M. L., and Baccarini, M., 1986, Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans, Infect. Immun. 54: 477–486.Google Scholar
  277. 277.
    Meister, H., Heymer, B., Schafer, H., and Haferkamp, 0., 1977, Role of Candida albicans in granulomatous tissue reactions. II. In vivo degradation of C. albicans in hepatic macrophages of mice, J. Infect. Dis. 135:235–242.PubMedCrossRefGoogle Scholar
  278. 278.
    Lehrer, R. I., Ferrari, L. G., Patterson-Delafield, J., and Sorrell, T., 1980, Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans, Infect. Immun. 28: 1001–1008.Google Scholar
  279. 279.
    Thaler, M., Pastakia, B., Shawker, T. H., O’Leary, T., Pizzo, P. A., 1988, Hepatic candidiasis in cancer patients: the evolving picture of the syndrome, Ann. Intern. Med. 108:88–100.PubMedCrossRefGoogle Scholar
  280. 280.
    Carstensen, H., Widding, E., Storm, K., Ostergaard, E., Herlin, T., 1990, Hepatosplenic candidiasis in children with cancer. Three cases in leukemia children and a literature review, Pediatr. Hematol. Oncol. 7:3–12.PubMedCrossRefGoogle Scholar
  281. 281.
    Pizzo, P. A., and Walsh, T. J., 1990, Fungal infections in the pediatric cancer patient. Semin. Oncol. 17:6–9.PubMedGoogle Scholar
  282. 282.
    Damodaran, V. N., and Chakravarty, S. C., 1973, Mechanism of production of Candida lesions in rabbits, J. Med. Microbiol. 6:287–292.CrossRefGoogle Scholar
  283. 283.
    Peterson, E. M., and Calderone, R. A., 1977, Growth inhibition of Candida albicans by rabbit alveolar macrophages, Infect. Immun. 15;910–915.PubMedGoogle Scholar
  284. 284.
    Peterson, E. M., and Calderone, R. A., 1978, Inhibition of specific amino acid uptake in Candida albicans by lysosomal extracts from rabbit alveolar macrophages, Infect. Immun. 21: 506–513.PubMedGoogle Scholar
  285. 285.
    Patterson-Delafield, J., Szklarek, D., Martinez, R. J., and Lehrer, R. I., 1981, Microbicidal cationic proteins of rabbit alveolar macrophages: amino acid composition and functional attributes, Infect. Immun. 31:723–731.PubMedGoogle Scholar
  286. 286.
    Selsted, M. E., Brown, D. M., DeLange, R. J., and Lehrer, R. I., 1983, Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages, J. Biol. Chem. 258:14485–14489.PubMedGoogle Scholar
  287. 287.
    Ganz, T., Sherman, M. P., Selsted, M. E., and Lehrer, R. I., 1985, Newborn rabbit alveolar macrophages are deficient in two microbicidal cationic peptides, MCP-1 and MCP-2, Am. Rev. Respir. Dis. 132:901–904.PubMedGoogle Scholar
  288. 288.
    D’Ambola, J. B., Sherman, M. P., Tashkin, D. P., Gong, H., Jr., 1988, Human and rabbit newborn lung macrophages have reduced anti-Candida activity, Pediatr. Res. 24:285–290.PubMedCrossRefGoogle Scholar
  289. 289.
    LaForce, F. M., Sharrar, R. G., and Arai, G., 1979, Characterization of yeast agglutinins in lavage fluid from lungs of rabbits, J Infect. Dis. 140:96–104.PubMedCrossRefGoogle Scholar
  290. 290.
    Arai, T., Mikami, Y., and Yokoyama, K., 1977, Phagocytosis of Candida albicans by rabbit alveolar macrophages and guinea pig neutrophils, Sabouraudia 15:171–177.PubMedCrossRefGoogle Scholar
  291. 291.
    Gontijo, P. P., Jr., and Wayne, L. G., 1978, Phagocytic and antimicrobial activities of rabbit peritoneal and alveolar macrophages activated with Mycobacterium bovis BCG on Candida albicans, Rev. Latinoam. Microbiol. 20:41–44.Google Scholar
  292. 292.
    Evans, Z. A., 1980, Tissue responses to the blastospores and hyphae of Candida albicans in the mouse, J. Med. Microbiol. 14:307–319.CrossRefGoogle Scholar
  293. 293.
    Nugent, K. M., and Onofrio, J. M., 1983, Pulmonary tissue resistance to Candida albicans in normal and in immunosuppressed mice, Am. Rev. Respir. Dis. 128:909–914.PubMedGoogle Scholar
  294. 294.
    Lal, S., Mitsuyama, M., Amako, K., and Nomoto, K., 1986, Enhanced clearance of Candida albicans from lung after intratracheal immunization, J Clin. Lab. Immunol. 21:23–30.Google Scholar
  295. 295.
    Lal, S., Mitsuyama, M., Miyata, M., Ogata, N., Amako, K., and Nomoto, K., 1986, Pulmonary defense mechanism in mice. A comparative role of alveolar macrophages and polymorphonuclear cells against infection with Candida albicans, J. Clin. Lab. Immunol. 19: 127–133.Google Scholar
  296. 296.
    Nugent, K. M., and Fick, R. B., Jr., 1987,Candidacidal factors in murine bronchoalveolar lavage fluid, Infect. Immun. 55:541–546.PubMedGoogle Scholar
  297. 297.
    Warr, G. A., and Jakab, G. J., 1979, Alterations in lung macrophage antimicrobial activity associated with viral pneumonia, Infect. Immun. 26:492–497.PubMedGoogle Scholar
  298. 298.
    Kurland, G., Cheung, A. T., Miller, M. E., Ayin, S. A., Cho, M. M., and Ford, E. W, 1988, The ontogeny of pulmonary defenses: alveolar macrophage function in neonatal and juvenile rhesus monkeys, Pediatr. Res. 23:293–297.PubMedCrossRefGoogle Scholar
  299. 299.
    Brummer, E., and Stevens, D. A., 1987, Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines, Clin. Exp. Immunol. 70:520–528.PubMedGoogle Scholar
  300. 300.
    Stanley, V. C., and Hurley, R., 1969, The growth of Candida species in cultures of mouse peritoneal macrophages, J. Pathol. 97:357–366.PubMedCrossRefGoogle Scholar
  301. 301.
    Ozato, K., and Uesaka, I., 1974, The role of macrophages in Candida albicans infection in vitro, Jap. J Microbiol. 18:29–35.PubMedGoogle Scholar
  302. 302.
    Sasada, M., and Johnston, R. B., Jr., 1980, Macrophage microbicidal activity: correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages, J. Exp. Med. 152:85–98.PubMedCrossRefGoogle Scholar
  303. 303.
    Nozawa, R. T., Sekiguchi, R., and Yokota, T., 1980, Stimulation by conditioned medium of L-929 fibroblasts, E. coli lipopolysaccharide, muramyl dipeptide of candidacidal activity of mouse macrophages, Cell. Immunol. 53:116–124.PubMedCrossRefGoogle Scholar
  304. 304.
    Maiti, P. K., Kumar, R., and Mohapatra, L. N., 1980, Candidacidal activity of mouse macrophages in vitro, Infect. Immun. 29:477–482.PubMedGoogle Scholar
  305. 305.
    Mor, N., and Goren, M. B., 1987,Discrepancy in assessment of phagosome-lysosome fusion with two lysosomal markers in murine macrophages infected with Candida albicans, Infect. Immun. 55:1663–1667.PubMedGoogle Scholar
  306. 306.
    Brummer, E., Morrison, C. J., and Stevens, D. A., 1985, Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi, Infect. Immun. 49: 724–730.PubMedGoogle Scholar
  307. 307.
    Kolotila, M. P., Smith, C. W, and Rogers, A. L., 1987, Candidacidal activity of macrophages from three mouse strains as demonstrated by a new method: neutral red staining, J. Med. Vet. Mycol. 25:283–290.PubMedCrossRefGoogle Scholar
  308. 308.
    Lehrer, R. I., Ferrari, L. G., and Patterson-Delafield, J., 1977, The fungicidal activity of rabbit macrophages, Clin. Res. 25:490A.Google Scholar
  309. 309.
    Kagaya, K., and Fukazawa, Y., 1981, Murine defense mechanisms against Candida albicans infection. II. Opsonization, phagocytosis and intracellular killing of C. albicans, Microbiol. Immunol. 25:807–818.PubMedGoogle Scholar
  310. 310.
    Brummer, E., and Stevens, D. A., 1989, Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon, J Med. Microbiol. 28:173–181.PubMedCrossRefGoogle Scholar
  311. 311.
    Diamond, R. D., and Haudenschild, C. C., 1981, Monocyte-mediated serum independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro, j Clin. Invest. 67: 173–182.PubMedCrossRefGoogle Scholar
  312. 312.
    Patterson-Delafield, J., Martinez, R. J., and Lehrer, R. I., 1980, Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism, Infect. Immun. 30:180–192.PubMedGoogle Scholar
  313. 313.
    Lehrer, R. I., Szklarek, D., Selsted, M. E., and Fleischmann, J., 1981, Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant, Infect. Immun. 33:775–778.PubMedGoogle Scholar
  314. 314.
    Mourad, S., and Friedman, L., 1961, Active immunization of mice against Candida albicans, Proc. Soc. Exp. Biol. Med. 106:570–572.PubMedCrossRefGoogle Scholar
  315. 315.
    Oblack, D. L., and Holder, I. A., 1979, Active immunization of mice against muscle damage mediated by Candida albicans, j Med. Microbiol. 12:503–506.CrossRefGoogle Scholar
  316. 316.
    Banerjee, U., Mohapatra, L. N., and Kumar, R., 1985, Effect of immunization with formalin killed cells in complete Freund’s adjuvant in experimental candidosis, Indian J Med. Res. 81:454–458.PubMedGoogle Scholar
  317. 317.
    Levy, R., Segal, E., and Eylan, E., 1981, Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions, Infect. Immun. 31:874–878.PubMedGoogle Scholar
  318. 318.
    Kuttin, E. S., Muller, J., Douchet, C., and Vogt, A., 1983, Immunological and pathological observations with Candida albicans-infected animals, Sabouraudia 21:185–194.PubMedCrossRefGoogle Scholar
  319. 319.
    Hasenclever, H. E, and Mitchell, W. 0., 1963, Acquired immunity to candidiasis in mice, J. Bacteriol. 86:401–406.PubMedGoogle Scholar
  320. 320.
    Giger, D. K., Domer, J. E., and McQuitty, J. T., Jr., 1978, Experimental murine candidiasis: pathologic and immune responses to cutaneous inoculation with Candida albicans, Infect. Immun. 19:499–509.PubMedGoogle Scholar
  321. 321.
    Scheld, W. M., Calderone, R. A., Brodeur, J. P., and Sande, M. A., 1983, Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis, Infect. Immun. 40:950–955.PubMedGoogle Scholar
  322. 322.
    Mourad, S., and Friedman, L., 1968, Passive immunization of mice against Candida albicans, Sabouraudia 6:103–105.PubMedCrossRefGoogle Scholar
  323. 323.
    Al-Doory, Y., 1970, An immune factor in baboon anti-Candida serum, Sabouraudia 8: 41–47.PubMedCrossRefGoogle Scholar
  324. 324.
    Pearsall, N. N., Adams, B. L., and Bunni, R., 1978, Immunologic responses to Candida albicans. III. Effect of passive transfer of lymphoid cells or serum on murine candidiasis, J. Immunol. 120:1176–1180.PubMedGoogle Scholar
  325. 325.
    Moser, S. A., and Domer, J. E., 1980, Effects of cyclophosphamide on experimental murine candidiasis, Infect. Immun. 27:376–386.PubMedGoogle Scholar
  326. 326.
    Kuruganti, U., Henderson, L. A., Garner, R. E., Asofsky, R., Baker, P. J., and Domer, J. E., 1988, Nonspecific and Candida-specific immune responses in mice suppressed by chronic administration of anti-g, J Leukoc. Biol. 44:422–433.PubMedGoogle Scholar
  327. 327.
    Matthews, R., Burnie, J., Smith, D., Clark, I., Midgley, J., Conolly, M., and Gazzard, B., 1988, Candida and AIDS: evidence for protective antibody, Lancet 2:263–266.Google Scholar
  328. 328.
    Domer, J. E., and Hector, R. H., 1987, Enhanced immune responses in mice treated with penicillin/tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans, Antimicrob. Agents Chemother. 31:691–697.CrossRefGoogle Scholar
  329. 329.
    Hurd, R. C., and Drake, C. H., 1953, Candida albicans infections in actively and passively immunized animals, Mycopathol. Mycol. Appi. 6:290–297.CrossRefGoogle Scholar
  330. 330.
    Miyake, T, Takeya, K., Nomoto, K., and Muraoka, S., 1977, Cellular elements in the resistance to Candida infection in mice. I. Contribution of T lymphocytes and phagocytes at various stages of infection, Microbiol. Immunol. 21:703–725.PubMedGoogle Scholar
  331. 331.
    Banerjee, U., Mohapatra, L. N., and Kumar, R., 1984, Role of antibody in defence against murine candidosis, Indian J. Med. Res. 79:760–765.PubMedGoogle Scholar
  332. 332.
    Giger, D. K., Domer, J. E., Moser, S. A., and McQuitty, J. T., Jr., 1978, Experimental murine candidiasis: pathological and immune responses in T-depleted mice, Infect. Immun. 21: 729–737.PubMedGoogle Scholar
  333. 333.
    Grubek, H., Szymanska, D., Trenkner, E,. Weyman-Rzucidlo, D., and Okon, M., 1970, Effect of anti-lymphocyte serum on experimental infection with Candida albicans in guinea pigs, Acta Microbiol. Pol. Ser. A 2:21–30.Google Scholar
  334. 334.
    Sohnle, P. G., Frank, M. M., and Kirkpatrick, C. H., 1976, Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs, J. Immunol. 117:523–530.PubMedGoogle Scholar
  335. 335.
    Cenci, E., Romani, L., Vecchiarelli, A., Puccetti, P., and Bistoni, E, 1989, Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice, Infect. Immun. 59:3581–3587.Google Scholar
  336. 336.
    Cenci, E., Romani, L., Vecchiarelli, A., Puccetti, P., and Bistoni, E, 1990, T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice, J. Immunol. 144:4333–4339.PubMedGoogle Scholar
  337. 337.
    Vecchiarelli, A., Cenci, E., Puliti, M., Blasi, E., Puccetti, P., Cassone, A., and Bistoni, E, 1989, Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state, Cell. Immunol. 124:334–344.PubMedCrossRefGoogle Scholar
  338. 338.
    Garner, R. E., Kuruganti, U., Czarniecki, C. W, Chiu, H. H., and Domer, J. E., 1989, In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon, Infect. Immun. 57:1800–1808.Google Scholar
  339. 339.
    Sen, P., Smith, J. K., Buse, M., Hsieh, H. C., Lavenhar, M. A., Lintz, D., and Louria, D. B., 1982, Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract, Sabouraudia 20:85–93.PubMedCrossRefGoogle Scholar
  340. 340.
    Kagaya, K., Shinoda, R., and Fukazawa, Y., 1981, Murine defense mechanisms against Candida albicans infection. I. Collaboration of cell-mediated and humoral immunities in protection against systemic C. albicans infection, Microbiol. Immunol. 25:647–654.PubMedGoogle Scholar
  341. 341.
    Sinha, B. K., Prasad, S., and Monga, D. P., 1987, Studies of experimental candidiasis in T-cell-deficient mice, Zbt. Bacteriol. Hyg. A 256:203–209.Google Scholar
  342. 342.
    Ashman, R. B., 1990, Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection, Immunol. Cell Biol. 68:15–20.PubMedCrossRefGoogle Scholar
  343. 343.
    Hurtrel, B., Lagrange, P. H., and Michel, J.-C., 1981, Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice, Infect. Immun. 31:95–101.PubMedGoogle Scholar
  344. 344.
    Salvin, S. B., Peterson, R. D. A., and Good, R. A., 1965, The role of the thymus in resistance to infection and endotoxin toxicity,. Lab. Clin. Med. 65:1004–1022.Google Scholar
  345. 345.
    Gordee, R. S., and Simpson, P. J., 1967, Relationships of x-irradiation to the enhancement of Candida albicans infections, J. Bacterial. 94:6–12.Google Scholar
  346. 346.
    Rogers, T. J., Balish, E., and Manning, D. D., 1976, The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis,J. Reticuloendothel. Soc. 20:291–298.PubMedGoogle Scholar
  347. 347.
    Ashman, R. B., 1987, Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex, Immunogenetics 25: 200–203.PubMedCrossRefGoogle Scholar
  348. 348.
    Sinha, B. K., Prasad, S., and Monga, D. P., 1987, Studies on the role of B-cells in the resistance of mice to experimental candidiasis, Zbl. Bakt. Hyg. A 266:316–322.Google Scholar
  349. 349.
    Mahanty, S., Greenfield, R. A., Joyce, W. A., and Kincade, R W, 1988, Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome, Infect. Immun. 56:3162–3166.PubMedGoogle Scholar
  350. 350.
    Marquis, G., Montplaisir, S., Pelletier, M., Auger, R, and Lapp, W. S., 1988, Genetics of resistance to infection with Candida albicans in mice, Br J. Exp. Path. 69:651–660.Google Scholar
  351. 351.
    Vecchiarelli, A., Cenci, E., Marconi, R, Rossi, R., Riccardi, C., and Bistoni, E, 1989, Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans, J. Med. Microbial. 30;183–192.CrossRefGoogle Scholar
  352. 352.
    Bistoni, E, Marconi, R, Frati, L., Bonmassar, E., and Garcia, E., 1982, Increase of mouse resistance to Candida albicans infection by thymosin al, Infect. Immun. 36:609–614.PubMedGoogle Scholar
  353. 353.
    Marquis, G., Montplaisir, S., Pelletier, M., Mousseau, S., and Auger, R, 1986, Strain-dependent differences in susceptibility of mice to experimental candidosis, j Infect. Dis. 154:906–909.PubMedCrossRefGoogle Scholar
  354. 354.
    Ashman, R. B., and Papadimitriou, J. M., 1987, Murine candidiasis. Pathogenesis and host responses in genetically distinct inbred mice, Immunol. Cell Biol. 65:163–171.PubMedCrossRefGoogle Scholar
  355. 355.
    Ashman, R. B., 1990, Murine candidiasis: susceptibility is associated with the induction of T cell-mediated, strain-specific autoreactivity, Immunol. Cell Biol. 68:179–185.PubMedCrossRefGoogle Scholar
  356. 356.
    Ashman, R. B., 1987, Murine candidiasis. III. Host inflammatory responses are regulated in part by class I MHC genes, J Immunogenet. 14:317–321.PubMedCrossRefGoogle Scholar
  357. 357.
    Ashman, R. B., and Papadimitriou, J. M., 1989, Genetic regulation of pathogenesis and host responses in fungal infection, in Immunology of Fungal Diseases (E. Kurstak, ed.), Marcel Dekker, Inc., New York, pp. 347–371.Google Scholar
  358. 358.
    Fischer, A., Ballet, J. J., and Griscelli, C., 1978, Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in serum of patients with chronic mucocutaneous candidiasis, j Clin. Inzest. 62:1005–1013.CrossRefGoogle Scholar
  359. 359.
    Witkin, S. S., Yu, R., and Ledger, W. J., 1983, Inhibition of Candida albicans-induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis, Am. J. Obstet. Gynecol. 147:809–811.PubMedGoogle Scholar
  360. 360.
    Borkowsky, W, and Valentine, E T., 1979, The proliferative response of human lymphocytes to antigen is suppressed preferentially by lymphocytes precultured with the same antigen, J Immunol. 122:1867–1873.PubMedGoogle Scholar
  361. 361.
    Rogers, T. J., and Balish, E., 1978, Effect of systemic candidiasis on blastogenesis of lymphocytes from germfree and conventional rats, Infect. Immun. 20:142–150.PubMedGoogle Scholar
  362. 362.
    Skerl, K. G. Scheld, W. M., Alliegro, G. M., and Calderone, R. A., 1980, Lymphocyte blastogenesis during experimental endocarditis caused by Candida albicans, J. Reticuloendothel. Soc. 28:495–506.Google Scholar
  363. 363.
    Piccolella, E., Lombardi, G., and Morelli, R., 1981, Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicanu,J. Immunol. 126: 2151–2159.Google Scholar
  364. 364.
    Rivas, V, and Rogers, T. J., 1983, Studies on the cellular nature of Candida albicans-induced suppression. J Immunol. 130:376–379.PubMedGoogle Scholar
  365. 365.
    Cuff, C. E, Rogers, C. M., Lamb, B.J., and Rogers, T. J., 1986, Induction of suppressor cells in vitro by Candida albicans, Cell. Immunol. 100:47–56.PubMedCrossRefGoogle Scholar
  366. 366.
    Nelson, R. D., Herron, M. J., McCormack, R. T., and Gehrz, R. C., 1984, Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharide, Infect. Immun. 43:1041–1046.PubMedGoogle Scholar
  367. 367.
    Witkin, S. S., 1986, Inhibition of Candida-induced lymphocyte proliferation by antibody to Candida albicans, Obstet. Gynecol. 68:696–699.PubMedGoogle Scholar
  368. 368.
    Podzorski, R. P., Herron, M. J., Fast, D. J., and Nelson, R. D., 1989, Pathogenesis of candidiasis. Immunosuppression by cell wall mannan catabolites, Arch. Surg. 124:1290–1294.PubMedCrossRefGoogle Scholar
  369. 369.
    Podzorski, R. E, Gray, G. R., and Nelson, R. D., 1990, Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro, J. Immunol. 144;707–716.PubMedGoogle Scholar
  370. 370.
    Cuff, C. E, Packer, B. J., and Rogers, T. J., 1989, A further characterization of Candida albicans-induced suppressor B-cell activity, Immunology 68:80–86.PubMedGoogle Scholar
  371. 371.
    Cuff, C. E, Taub, D. D., and Rogers, T. J., 1989, The induction of T-suppressor cells with a soluble extract of Candida albicans, Cell. Immunol. 122:71–82.CrossRefGoogle Scholar
  372. 372.
    Segal, E., Schwartz, J., Altboun, Z., Vardinon, N., and Eylan, E., 1977, Suppressive action of Candida albicans on the immune response in guinea pigs,.Vlicrobios 19:79–87.Google Scholar
  373. 373.
    Vardinon, N., and Segal, E., 1979, Suppressive action of Candida albicans on the immune response in mice, Exp. Cell Biol. 47:275–280.PubMedGoogle Scholar
  374. 374.
    Segal, E., Sandovsky-Losica, H., and Vardinon, N., 1980, Suppressive action of cytoplasmic and metabolic extracts of Candida albicans on the immune response in guinea pigs, Mycopathologia 72:121–128.PubMedCrossRefGoogle Scholar
  375. 375.
    Cutler, J. E., and Lloyd, R. K., 1982, Enhanced antibody responses induced by Candida albicans in mice, Infect. Immun. 38:1102–1108.PubMedGoogle Scholar
  376. 376.
    Carroty, E. W, and Domer, J. E., 1985, Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein, Infect. Immun. 49:172–181.Google Scholar
  377. 377.
    Domer, J. E., Stashak, P. W, Elkins, K., Prescott, B., Caldes, G., and Baker, P. J., 1986, Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components, Cellular Immunol. 101:403–414.CrossRefGoogle Scholar
  378. 378.
    Domer, J. E., Elkins, K. L., Ennist, D. L., Stashak, P. W, Garner, R. E., and Baker, E J., 1987, Immunoenhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein, Infect. Immun. 55:2619–2624.PubMedGoogle Scholar
  379. 379.
    Domer, J., Garner, R., and Befidi-Mengue, R., 1989, Mannan as an antigen in cell-mediated immune (CMI) assays and as a modulator of mannan-specific CMI, Infect. Immun. 57: 693–700.PubMedGoogle Scholar
  380. 380.
    Garner, R. E., Childress, A. M., Human, L. G., and Domer, J. E., 1990, Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells, Infect. Immun. 58:2613–2620.PubMedGoogle Scholar
  381. 381.
    Piccolella, E., Lombardi, G., and Morelli, R., 1980, Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response, J. Immunol. 125:2082–2088.PubMedGoogle Scholar
  382. 382.
    Lombardi, G., Vismara, D., Piccolella, E., Colizzi, V., and Asherson, G. L., 1985, A nonspecific inhibitor produced by Candida albicans activated T cells impairs cell proliferation by inhibiting interleukin-1 production, Clin. Exp. Immunol. 60:303–310.PubMedGoogle Scholar
  383. 383.
    Peat, S., Whelan, W. J., and Edwards, T. E., 1961, Polysaccharide of baker’s yeast. Part IV. Mannan, J. Chem. Soc. (London) 1:29–34.Google Scholar
  384. 384.
    Durandy, A., Fischer, A., Charron, D., and Griscelli, G., 1986, Specific binding of antigen onto human T lymphocytes, J. Clin. Invest. 77:1557–1564.PubMedCrossRefGoogle Scholar
  385. 385.
    Fischer, A., Pichat, L., Audinot, M., and Griscelli, C., 1982, Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness, Clin. Exp. Immunol. 47:653–660.PubMedGoogle Scholar
  386. 386.
    Wright, C. D., Herron, M. J., Gray, G. R., Holmes, B., and Nelson, R. D., 1981, Influence of yeast mannan on human neutrophil functions: inhibition of release of myeloperoxidase related to carbohydrate-binding property of the enzyme, Infect. Immun. 32:731–738.PubMedGoogle Scholar
  387. 387.
    Winner, H. I., and Hurley, R., 1964, Candida Albicans, J. and A. Churchill Ltd, London.Google Scholar
  388. 388.
    Taschdjian, D. L., Kozinn, P. J., and Caroline, L., 1964, Immune studies in candidiasis. III. Precipitating antibodies in systemic candidiasis, Sabouraudia 3:312–320.PubMedCrossRefGoogle Scholar
  389. 389.
    de Repentigny; L., and Reiss, E., 1984, Current trends in immunodiagnosis of candidosis and aspergillosis, Rev. Infect. Dis. 6:301–312.Google Scholar
  390. 390.
    Bennett, J. E., 1987, Rapid diagnosis of candidiasis and aspergillosis, Rev. Infect. Dis. 9: 398–402.PubMedCrossRefGoogle Scholar
  391. 391.
    de Repentigny, L., 1989, Serological techniques for diagnosis of fungal infection, Eui: J. Clin.Vlicrobiol. Infect. Dis. 81:362–375.CrossRefGoogle Scholar
  392. 392.
    Evans, E. G. V, Richardson, M. D., Odds, E C., and Holland, K. T., 1973, Relevance of antigenicity of Candida albicans growth phases to diagnosis of systemic candidiasis, Br: Med. J. 4:86–87.CrossRefGoogle Scholar
  393. 393.
    Syverson, R. E., Buckley, H. R., and Campbell, C. C., 1975, Cytoplasmic antigens unique to the mycelial or yeast phase of Candida albicans, Infect. Immun. 12:1184–1188.Google Scholar
  394. 394.
    Manning, M., and Mitchell, T. G., 1980, Morphogenesis of Candida albicans and cytoplasmic proteins associated with differences in morphology; strain, or temperature, Bacteriol. 144: 258–273.Google Scholar
  395. 395.
    Ho, Y. M., Ng, M. H., and Huang, C. T., 1979, Antibodies to germinating and yeast cells of Candida albicans in human and rabbit sera, J. Clin. Pathol. 32:399–405.PubMedCrossRefGoogle Scholar
  396. 396.
    Smail, E. H., and Jones, J. M., 1984, Demonstration and solubilization of antigens expressed primarily on the surfaces of Candida albicans germ tubes, Infect. Immun. 45:74–81.PubMedGoogle Scholar
  397. 397.
    Sundstrom, P. M., and Kenny, G. E., 1984, Characterization of antigens specific to the surface of germ tubes of Candida albicans by immunofluorescence, Infect. Immun. 43: 850–855.PubMedGoogle Scholar
  398. 398.
    Ponton, J., and Jones, J. M., 1986, Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blot techniques, Infect. Immun. 53:565–572.PubMedGoogle Scholar
  399. 399.
    Brawner, D. J., and Cutler, J. E., 1984, Variability in expression of a cell surface determinant as evidenced by an agglutinating monoclonal antibody, Infect. Immun. 43:966–972.PubMedGoogle Scholar
  400. 400.
    Brawner, D. J., and Cutler, J. E., 1986, Variability in expression of cell surface antigens of Candida albicans during morphogenesis, Infect. Immun. 51;337–343.PubMedGoogle Scholar
  401. 401.
    Chaffin, W. L., Skudlarek, J., and Morrow, K. J., 1988, Variable expression of a surface determinant during proliferation of Candida albicans, Infect. Immun. 56:302–309.Google Scholar
  402. 402.
    Summers, D. E, Grollman, A. E, and Hasenclever, H. E, 1964, Polysaccharide antigens of Candida cell wall, J. Immunol. 92:491–499.PubMedGoogle Scholar
  403. 403.
    Syverson, R. E., and Buckley, H. R., 1977, Cell wall antigens in soluble cytoplasmic extracts of Candida albicans as demonstrated by crossed-immunoelectrophoresis with concanavalin A, J Immunol. Methods 18:149–156.CrossRefGoogle Scholar
  404. 404.
    Munoz, M., Estes, G., Kilpatrick, M., DiSalvo, A., and Virella, G., 1980, Purification of cytoplasmic antigens from the mycelial phase of Candida albicans: possible advantages of its use in Candida serology, Mycopathologia 72:47–53.PubMedCrossRefGoogle Scholar
  405. 405.
    Taschdjian, C. L., Dobbin, G. B., Kozinn, P. J., and Caroline, L., 1964, Experimental and preliminary clinical studies on antibody formation in systemic candidiasis, Sabouraudia 3: 129–139.PubMedCrossRefGoogle Scholar
  406. 406.
    Remington, J. S., Gaines, J. D., and Gilmer, M. A., 1972, Demonstration of Candida precipitins in human sera by counter-immunoelectrophoresis, Lancet 1:413.PubMedCrossRefGoogle Scholar
  407. 407.
    Axelsen, N. H., Buckley, H. R., Drouhet, E., Budtz-Jorgensen, E., Hattel, T., and Andersen, P. L., 1975, Crossed immunoelectrophoretic analysis of precipitins to Candida albicans in deep Candida infection, Scand. J Immunol. 4:217–230.CrossRefGoogle Scholar
  408. 408.
    Lehmann, P. E, and Reiss, E., 1980, Comparison by ELISA of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients, Mycopathologia 70: 89–93.PubMedCrossRefGoogle Scholar
  409. 409.
    Meckstroth, K. L., Reiss, E., Keller, J. W, and Kaufman, L., 1981, Detection of antibodies and antigenemia in leukemic patients with candidiasis by enzyme-linked immunosorbent assay, J. Infect. Dis. 144:24–32.PubMedCrossRefGoogle Scholar
  410. 410.
    Odds, E C., Evans, E. G. V., and Holland, K. T., 1975, Detection of Candida precipitins. A comparison of double diffusion and counter immunoelectrophoresis, J. Immunol. Methods 7: 211–218.PubMedCrossRefGoogle Scholar
  411. 411.
    Harding, S. A., Sanford, G. R., and Merz, W. G., 1976, Three serologic tests for candidiasis. Diagnostic value in distinguishing deep or disseminated infection from superficial infection or colonization, Am. J. Clin. Pathol. 65:1001–1009.PubMedGoogle Scholar
  412. 412.
    Dee, T. H., and Rytel, M. W, 1977, Detection of Candida serum precipitins by counterimmunoelectrophoresis: an adjunct in determining significant candidiasis, J. Clin. Microbiol. 5:453–457.PubMedGoogle Scholar
  413. 413.
    Merz, W. G., Evans, G. L., Shadomy, S., Anderson, S., Kaufman, L., Kozinn, P. J., Mackenzie, D. W, Protzman, W. P., and Remington, J. S., 1977, Laboratory evaluation of serological tests for systemic candidiasis: a cooperative study, J Clin. Microbiol. 5:596–603.PubMedGoogle Scholar
  414. 414.
    Kozinn, P. J., Taschdjian, C. L., Goldberg, P. K., Protzmann, W. P., Mackenzie, D. W. R., Remington, J. S., Anderson, S., and Seelig, M. S., 1978, Efficacy of serological tests in the diagnosis of systemic candidiasis, Am. J Clin. Pathol. 70:893–898.PubMedGoogle Scholar
  415. 415.
    Dee, T. H., Johnson, G. M., and Berger, C. S., 1981, Sensitivity specificity, and predictive value of anti-Candida serum precipitin and agglutinin quantification: comparison of counterimmunoelectrophoresis and latex agglutination, j Clin. Microbiol. 13:750–753.PubMedGoogle Scholar
  416. 416.
    Bisbe, J., Miro, J. M., Torres, J. M., Latorre, X., Alia, C., Amaral, M., Estivill, D., Mallalas, J., Trilla, A., and Soriano, E., 1989, Diagnostic value of serum antibody and antigen detection in heroin addicts with systemic candidiasis, Rev. Infect. Dis. 11:310–315.PubMedCrossRefGoogle Scholar
  417. 417.
    Syverson, R. E., Buckley, H. R., and Gibian, B. A., 1978, Increasing the predictive value positive of the precipitin test for the diagnosis of deep-seated candidiasis, Am. J. Clin. Pathol. 70:826–831.PubMedGoogle Scholar
  418. 418.
    Glew, R. H., Buckley, H. R., Rosen, H. M., Moellering, R. C., and Fischer, J. E., 1978, Serologic tests in the diagnosis of systemic candidiasis. Enhanced diagnostic accuracy with crossed immunoelectrophoresis, Am. J. Med. 64:586–591.PubMedCrossRefGoogle Scholar
  419. 419.
    Poulain, D., and Pinon, J. M., 1986, Diagnosis of systemic candidiasis: development of cocounterimmunoelectrophoresis, Eur. j Clin. Microbiol. 5:420–426.PubMedCrossRefGoogle Scholar
  420. 420.
    Poulain, D., and Pinon, J. M., 1986, Application of co-counterimmunoelectrophoresis, Eur. J. Clin Microbiol. 5:427–434.Google Scholar
  421. 421.
    Bougnoux, M.-E., Hill, C., Moissenet, D., de Chavin, M. E, Bonnay, M., Vicens-Sprauel, I., Pietri, F., McNeil, M., Kaufman, L., Dupouy-Camet, J,. Bohuon, C., and Andremont, A., 1990, Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis, J. Clin. Microbiol. 28:905–909.PubMedGoogle Scholar
  422. 422.
    Jones, J. M., 1980, Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice and humans, Infect. Immun. 30:78–89.PubMedGoogle Scholar
  423. 423.
    Matthews, R. C., Burnie, J. P., and Tabaqchali, S., 1984, Immunoblot analysis of the serologic response in systemic candidosis, Lancet 2:1415–1418.PubMedCrossRefGoogle Scholar
  424. 424.
    Au-Young, J. K., Troy, E. A., and Goldstein, E., 1985, Serologic analysis of antigen-specific reactivity in patients with systemic candidiasis, Diag. Microbiol. Infect. Dis. 3:419–432.CrossRefGoogle Scholar
  425. 425.
    Gatermann, S., Heesemann, J., and Laufs, R., 1986, Identification of Candida albicans antigens recognized by sera of patients with candidiasis, Mykosen 29:343–354.PubMedCrossRefGoogle Scholar
  426. 426.
    Strockbine, N. A., Largen, M. T., Zweibel, S. M., and Buckley, H. R., 1984, Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera, Infect. Immun. 43:715–721.PubMedGoogle Scholar
  427. 427.
    Porsius, J. C., van Vleit, H. J., van Zeijl, J. H., Goessens, W. H., and Michel, M. E, 1990, Detection of an antibody response in immunocompetent patients with systemic candidiasis or Candida albicans colonization, Eur. J. Clin. Microbiol. Infect. Dis. 9:352–355.PubMedCrossRefGoogle Scholar
  428. 428.
    Greenfield, R. A., and Jones, J. M., 1981, Purification and characterization of a major cytoplasmic antigen of Candida albicans, Infect. Immun. 34:469–477.Google Scholar
  429. 429.
    Fiss, E., and Buckley, H. R., 1987, Purification of actin from Candida albicans and comparison with the Candida 48,000-Mr Protein, Infect. Immun. 55:2324–2326.PubMedGoogle Scholar
  430. 430.
    Mason, A. B., Brandt, M. E., and Buckley, H. R., 1989, Enolase activity associated with Candida albicans cytoplasmic antigen, Yeast 5:231–239.Google Scholar
  431. 431.
    Franklyn, K. M., Warmington, J. R., Ott, A. K., and Ashman, R. B., 1990, An immunodominant antigen of Candida albicans shows homology to the enzyme enolase, Immunol. Cell Biol. 68:173–178.PubMedCrossRefGoogle Scholar
  432. 432.
    Matthews, R. C., Burnie, J. P., and Tabaqchali, S., 1987, Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans, J. Clin. Microbiol. 25:230–237.Google Scholar
  433. 433.
    Matthews, R., Wells, C., and Burnie, J. P., 1988, Characterization and cellular localization of the immunodominant 47-Kda antigen of Candida albicans, J. Med. Microbiol. 27:227–232.CrossRefGoogle Scholar
  434. 434.
    Manning-Zweerink, M., Maloney, C. S., Mitchell, T. G., and Weston, H., 1986, Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera, J Clin. Microbiol. 23:46–52.PubMedGoogle Scholar
  435. 435.
    Reen, D. J., 1988, Assessment of immunoblotting in the investigation of specific immune responses during infection, Biochem. Soc. Trans. 16:132–134.PubMedGoogle Scholar
  436. 436.
    Weller, B. I., Simmons, P. D., Ivanyl, L., 1990, Identification of immunodominant antigens of Candida albicans in patients with superficial candidosis, Clin. Immunol. Immunopathol. 54: 347–353.PubMedCrossRefGoogle Scholar
  437. 437.
    Greenfield, R. A., Bussey, M. J., Stephens, J. L., and Jones, J. M., 1983, Serial enzyme-linked immunosorbent assays for antibody to Candida antigens during induction chemotherapy for acute leukemia, J. Infect. Dis. 148:275–283.PubMedCrossRefGoogle Scholar
  438. 438.
    Strockbine, N. A., Largen, M. T., and Buckley, H. R., 1984, Production and characterization of three monoclonal antibodies to Candida albicans proteins, Infect. Immun. 43:1012–1018.PubMedGoogle Scholar
  439. 439.
    Ho, Y. M., Ng, M. H., Teoh-Chan, C. H., Yue, P. C. K., and Huang, C. T., 1976, Indirect immunofluorescence assay for antibody to germ tube of Candida albicans-a new diagnostic test, J. Clin. Pathol. 29:1007–1010.PubMedCrossRefGoogle Scholar
  440. 440.
    Quindos, G., Ponton, J., and Cisterna, R., 1987, Detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidiasis, Eur. J. Clin. Microbiol. 6:142–146.PubMedCrossRefGoogle Scholar
  441. 441.
    Quindos, G., Ponton, J., Cisterna, R., and Mackenzie, D. W. R., 1990, Value of detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidosis, Eur. J. Clin. Microbiol. Infect. Dis. 9:178–183.PubMedCrossRefGoogle Scholar
  442. 442.
    McHugh, T. M., Wang, Y. J., Chong, H. O., Blackwood, L. L., and Stites, D. P., 1989, Development of a microsphere-based fluorescent immunoassay and its comparison to an enzyme immunoassay for the detection of antibodies to three antigen preparations from Candida albicans, J Immunol. Methods 116:213–219.CrossRefGoogle Scholar
  443. 443.
    Weiner, M. H., and Yount, W J., 1976, Mannan antigenemia in the diagnosis of invasive Candida infections, J. Clin. Invest. 58:1045–1053.PubMedCrossRefGoogle Scholar
  444. 444.
    Kerkering, T. M., Espinel-Ingroff, A., and Shadomy, S., 1979, Detection of Candida antigenemia by counterimmunoelectrophoresis in patients with invasive candidiasis, J. Infect. Dis. 140:659–664.PubMedCrossRefGoogle Scholar
  445. 445.
    Weiner, M. H., and Coats-Stephen, M., 1979, Immunodiagnosis of systemic candidiasis: mannan antigenemia detected by radioimmunoassay in experimental and human infections, J. Infect. Dis. 140:989–993.PubMedCrossRefGoogle Scholar
  446. 446.
    Segal, E., Berg, R. A., Pizzo, P. A., and Bennett, J. E., 1979, Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique, J. Clin. Microbiol. 10:116–118.PubMedGoogle Scholar
  447. 447.
    Reiss, E., Stockman, L., Kuykendall, R. J., and Smith, S. J., 1981, Dissociation of mannanserum complexes and detection of Candida albicans mannan by enzyme immunoassay variations, Clin. Chem. 28:306–310.Google Scholar
  448. 448.
    Lew, M. A., Siber, G. R., Donahue, D. M., and Maiorca, E, 1982, Enhanced detection with an enzyme-linked immunosorbent assay of Candida mannan in antibody-containing serum after heat extraction, J. Infect. Dis. 145:45–56.PubMedCrossRefGoogle Scholar
  449. 449.
    Lemieux, C., St-Germain, G., Vincelette, J., Kaufman, L., and deRepentigny, L., 1990, Collaborative evaluation of antigen detection by a commercial latex agglutination test and enzyme immunoassay in the diagnosis of invasive candidiasis, J. Clin. Microbiol. 28: 249–253.PubMedGoogle Scholar
  450. 450.
    Kahn, E. W, and Jones, J. M., 1986, Latex agglutination test for detection of Candida antigens in sera of patients with invasive candidiasis, J Infect. Dis. 153:579–585.PubMedCrossRefGoogle Scholar
  451. 451.
    deRepentigny, L., Marr, L. D., Keller, J. W, Carter, A. W, Kuykendall, R. J., Kaufman, L., and Reiss, E., 1985, Comparison of enzyme immunoassay and gas—liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients, J. Clin. Microbiol. 21: 972–979.Google Scholar
  452. 452.
    Phillips, E, Dowd, A., Jewesson, E, Radigan, G., Tweeddale, M. G., Clarke, A., Geere, I., and Kelly, M., 1990, Nonvalue of antigen detection immunoassays for diagnosis of candidemia, J. Clin. Microbiol. 28:2320–2326.PubMedGoogle Scholar
  453. 453.
    Fung, J. C., Donta, S. T, and Tilton, R. C., 1986, Candida detection system (CAND-TEC) to differentiate between colonization and disease, J. Clin. Microbiol. 24:542–547.Google Scholar
  454. 454.
    Fujita, S., Matsubara, E, and Matsuda, T., 1986, Enzyme-linked immunosorbent assay measurement of fluctuations in antibody titer and antigenemia in cancer patients with and without candidiasis, J. Clin. Microbiol. 23:568–575.PubMedGoogle Scholar
  455. 455.
    Gentry, L. O., Wildinson, I. D., Lea, S. S., and Price, M. E, 1983, Latex agglutination test for detection of Candida antigen in patients with disseminated disease, Eur. J. Clin. Microbiol. 2: 122–128.PubMedCrossRefGoogle Scholar
  456. 456.
    Piens, M.-A., Guyotat, D., Archimbaud, E., Plotton, C., Maupas, J., Mojon, M., and Fiere, D., 1988, Evaluation of a Candida antigen detection test (Cand-TecTM) in the diagnosis of deep candidiasis in neutropenic patients, Eur. J. Cancer Clin. Oncol. 24:1655–1659.PubMedCrossRefGoogle Scholar
  457. 457.
    Ness, M. J., Vaughan, W. P., and Woods, G. L., 1989, Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients, J. Infect. Dis. 159:495–502.PubMedCrossRefGoogle Scholar
  458. 458.
    Escuro, R. S., Jacobs, M., Gerson, S. L., Machicao, A. R., and Lazarus, H. M., 1989, Prospective evaluation of a Candida antigen detection test for invasive candidiasis in immunocompromised adult patients with cancer, Am. J. Med. 87:621–627.PubMedCrossRefGoogle Scholar
  459. 459.
    Price, M. E, and Gentry, L. O., 1990, Candida antigen latex test, J. Infect. Dis. 161:807.CrossRefGoogle Scholar
  460. 460.
    Price, M. E, and Gentry, L. O., 1986, Incidence and significance of Candida antigen in low-risk and high-risk patient populations, Eur. J. Clin. Microbiol. 5:416–419.PubMedCrossRefGoogle Scholar
  461. 461.
    Bailey, J. W, Sada, E., Brass, C., and Bennett, J. E., 1985, Diagnosis of systemic candidiasis by latex agglutination for serum antigen, J Clin. Microbiol. 21:749–752.PubMedGoogle Scholar
  462. 462.
    Ness, M. J., Rennard, S. I., Vaughn, W. P., Ghafouri, M. A., and Linder, J. A., 1988, Detection of Candida antigen in bronchoalveolar lavage fluid, Acta Cytol. 32:347–352.PubMedGoogle Scholar
  463. 463.
    Araj, G. E, Hopfer, R. L., Chesnut, S., Fainstein, V., and Bodey, G. R, 1982, Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patients, J. Clin. Microbiol. 16:46–52.PubMedGoogle Scholar
  464. 464.
    Burnie, J., 1985, A reverse passive latex agglutination test for the diagnosis of systemic candidosis, J. Immunol. Methods 82:267–280.PubMedCrossRefGoogle Scholar
  465. 465.
    Ferraira, R. R, Yu, B., Niki, Y., and Armstrong, D., 1990, Detection of Candida antigenuria in disseminated candidiasis by immunoblotting, J Clin. Microbiol. 28:1075–1078.Google Scholar
  466. 466.
    Longbottom, J. J., Murray, I. G., and Pepys, J., 1963, Diagnosis of fungal disease, in: Clinical Aspects of Immunology, (P. L. Gell and R. R. A. Coombs, eds.), Blackwell Scientific Publications, Oxford, p. 71.Google Scholar
  467. 467.
    Shannon, D. C., Gohnson, G., Rosen, E. S., and Austen, K. E, 1966, Cellular reactivity to Candida albicans antigen, N. Engl. J. Med. 275:690–693.PubMedCrossRefGoogle Scholar
  468. 468.
    Hassett, A. M., Woods, R. J., Temperley, I. J., and Mullins, G. M., 1977, Cell mediated immunity to recall antigens in vivo and in vitro, Irish J. Med. Sci. 146:167–174.PubMedCrossRefGoogle Scholar
  469. 469.
    Ferguson, A. C., Kershnar, H. E., Collin, W. K., and Stiehm, E. R., 1977, Correlation of cutaneous hypersensitivity with lymphocyte response to Candida albicans, Am. J. Clin. Pailful. 68:499–540.Google Scholar
  470. 470.
    Hogan, T. E, Borden, E. C., Freeberg, B. L., Vieau, J., Hsieh, E.-Y., and Crowley, J., 1980, Enhancement in recall antigen responses by frequent, repetitive skin testing with Candida, mumps, and streptokinase-streptodornase in 38 normal adults, Cancer Immunol. Immunother. 10:27–31.CrossRefGoogle Scholar
  471. 471.
    Valdimarsson, H., Higgs, J. M., Wells, R. S., Yamamura, M., Hobbs, J. R., and Holt, P. J. L., 1973, Immune abnormalities associated with chronic mucocutaneous candidiasis, Cellular Immunol. 6:348–361.CrossRefGoogle Scholar
  472. 472.
    Bice, D. E., Lopez, M., Rothschild, H., and Salvaggio, J., 1974, Comparison of Candida-delayed hypersensitivity skin test size with lymphocyte transformation, migration inhibitory factor production and antibody titer, Int. Arch. Allergy 47:54–62.PubMedCrossRefGoogle Scholar
  473. 473.
    Alford, R. H., 1973, Transformation of lymphocytes of normal and hospitalized adults by Candida albicans extract, Proc. Soc. Exp. Biol. Med. 144:826–829.PubMedCrossRefGoogle Scholar
  474. 474.
    Foroozanfar, N., Yamamura, M., and Hobbs, J. R., 1974, Standardization of lymphocyte transformation to Candida immunogen, Clin. Exp. Immunol. 16:301–310.PubMedGoogle Scholar
  475. 475.
    Esch, R. E., and Buckley, C. E., 1988, A novel Candida albicans skin test antigen: efficacy and safety in man, J. Biol. Standardization 16:33–43.CrossRefGoogle Scholar
  476. 476.
    Hurtrel, B., and Lagrange, P. H., 1978, Delayed type hypersensitivity reactions to Candida albicans in mice, Ann. D’Immunol. C129:653–668.Google Scholar
  477. 477.
    Ponton, J., Quindos, G., Regulez, P., and Cisterna, R., 1985, Cellular and humoral immune responses to Candida-albicans in subcutaneously infected mice, Mycopathologia 92:11–18.PubMedCrossRefGoogle Scholar
  478. 478.
    Suzuki, M., and Hayashi, Y., 1975, Skin reaction and macrophage migration inhibition tests for polysaccharides from Aspergillus fumigatus and Candida albicans, Jap. J. Microbiol. 19: 355–362.PubMedGoogle Scholar
  479. 479.
    Reiss, E., Stone, S. H., and Hasenclever, H. R., 1974, Serologic and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls, Infect. Immun. 9:881–890.PubMedGoogle Scholar
  480. 480.
    Ellsworth, J. H., Reiss, E., Bradley, R. L., Chmel, H., and Armstrong, D., 1977, Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannans separated by affinity for concanavalin A., J. Clin. Microbiol. 5:91–99.PubMedGoogle Scholar
  481. 481.
    Domer, J. E., and Moser, S. A., 1978, Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge, Infect. Immun. 20:88–98.PubMedGoogle Scholar
  482. 482.
    Moser, S. A., Domer, J. E., and Mather, E J., 1980, Experimental murine candidiasis: cell mediated immunity after cutaneous challenge, Infect. Immun. 27:140–149.PubMedGoogle Scholar
  483. 483.
    Levy, R., Segal, E., Eylan, E., and Barr-Nea, L., 1983, Cell-mediated immunity following experimental vaccinations with Candida albicans ribosomes, Mycopathologia 83:161–168.PubMedCrossRefGoogle Scholar
  484. 484.
    Crowle, A. J., 1975, Delayed hypersensitivity in the mouse, Adv. Immunol. 20:197–264.PubMedCrossRefGoogle Scholar
  485. 485.
    Dikeacou, R., and Drouhet, E., 1981, Cellular inflammatory response to fungal antigen studied with the skin window technique—correlation of the exudate with the evolution of the mycotic infection, Agents Actions 11:631–633.PubMedCrossRefGoogle Scholar
  486. 486.
    Winterrowd, G. E., and Cutler, J. E., 1983, Candida albicans-induced agglutinin and immunoglobulin E responses in mice, Infect. Immun. 41:33–38.PubMedGoogle Scholar
  487. 487.
    Domer, J. E., 1989, Candida cell wall mannan: a polysaccharide with diverse immunologic properties, CRC Crit. Rev. Microbiol. 17:33–51.CrossRefGoogle Scholar
  488. 488.
    Ausiello, C. M., Spagnoli, G. C., Boccanera, M., Casalinuovo, I., Malavasi, E, Casciani, C. U., and Cassone, A., 1986, Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions, J Med. Microbiol. 22:195–202.PubMedCrossRefGoogle Scholar
  489. 489.
    Piccolella, E., Lombardi, G., and Morelli, R., 1980, Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response, J. Immunol. 125:2082–2088.PubMedGoogle Scholar
  490. 490.
    Gettner, S. M. M., and Mackenzie, D. W. R., 1981, Responses of human peripheral lymphocytes to soluble and insoluble antigens of Candida albicans, j Med. Microbiol. 14: 333–340.CrossRefGoogle Scholar
  491. 491.
    Tollemar, J., Ringden, O., and Holmberg, K., 1989, Candida albicans: mannan and protein activation of cells from various human lymphoid organs, Scand. j Immunol. 30:473–480.PubMedCrossRefGoogle Scholar
  492. 492.
    Kerridge, D., and Whelan, W. L., 1984, The polyene macrolide antibiotics and 5-fluorocytosine Molecular actions and interactions, in: Mode of Action of Antifungal Agents (A. P. J. Trinci, and J. E Riley, eds.), London, British Mycological Society, pp. 343–375.Google Scholar
  493. 493.
    Bennett, J. E., 1990, Antifungal agents, in: Principles and Practice of Infectious Diseases third edition, (G. L. Mandell, R. G. Douglas, and J. E. Bennett, eds.), Churchill Livingstone, New York, pp. 361–370.Google Scholar
  494. 494.
    Smego, R. A., Jr., Perfect, J. R., Durack, D. T, 1984, Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis, Rev. Infect. Dis. 6:791–801.PubMedCrossRefGoogle Scholar
  495. 495.
    Diasio, R. B., Bennett, J. E., and Myers, C. E., 1978, Mode of action of 5-fluorocytosine, Biochem. Pharmacol. 27:703–707.PubMedCrossRefGoogle Scholar
  496. 496.
    Polak, A., and Scholer, H. J., 1975, Mode of action of 5-fluorocytosine and mechanisms of resistance, Chemother. 21:113–130.CrossRefGoogle Scholar
  497. 497.
    Vanden Bossche, H., Bellens, D., Cools, W, Gorrens, J., Marichal, P., Verhoeven, H., Willemsens, G., De Coster, R., Beerens, D., Haelterman, C., Coene, M.-C., Lauwers, W, and Le Jeune, L., 1986, Cytochrome P-450: target for itraconazole, Drug Dev. Res. 8:287–298.CrossRefGoogle Scholar
  498. 498.
    Dismukes, W. E., 1988, Azole antifungal drugs: old and new, Ann. Intern. Med. 109: 177–179.PubMedCrossRefGoogle Scholar
  499. 499.
    Meunier, E, Gerain, J., Snoeck, R., Libotte, E, Lambert, C., Cueppers, A. M., 1987, Fluconazole therapy of oropharyngeal candidiasis in cancer patients, in: Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents (R. A. Fromtling, ed.), J. R. Prouss, Barcelona, pp. 169–174.Google Scholar
  500. 500.
    Dupont, B., and Drouhet, E., 1988, Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients, J. Med. Vet. Mycol. 26:67–71.PubMedCrossRefGoogle Scholar
  501. 501.
    Meunier-Carpentier, E, Cruciani, M., Klastersky, J., 1983, Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients, Eur. J. Cancer Clin. Oncol. 19:43–48.CrossRefGoogle Scholar
  502. 502.
    Jones, P. G., Kauffmann, C. A., McAuliffe, L. S., Liepman, M. K., and Bergman, A. G., 1984, Efficacy of ketoconazole versus nystatin in prevention of fungal infections in neutropenic patients, Arch. Intern. Med. 144:549–551.PubMedCrossRefGoogle Scholar
  503. 503.
    Meunier, E, Leleux, A., Snoeck, R., Gerain, J., Lambert, C,. Cueppers, A. M., 1989, Chemoprophylaxis of fungal infections, in: Diagnosis and Therapy of Systemic Fungal Infections (K. Holmberg, and R. Meyer, eds.), Raven Press, New York, pp. 167–177.Google Scholar
  504. 504.
    Edwards, J. E., Jr., 1990, Candida species, in: Principles and Practice of Infectious Diseases (G. L. Mandell, R. G. Douglas, and J. E. Bennett, eds.), Churchill-Livingstone, New York, pp. 1943–1958.Google Scholar
  505. 505.
    Meunier, E, 1989, Candidiasis, Eur. j Clin. Microbiol. Infect. Dis. 8:438 447.Google Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Judith E. Domer
    • 1
  • Robert I. Lehrer
    • 2
  1. 1.Department of Microbiology and ImmunologyTulane University School of MedicineNew OrleansUSA
  2. 2.Department of MedicineUCLA School of MedicineLos AngelesUSA

Personalised recommendations